Home Ricerca Sedi Chi siamo Organigramma Personale Contatti Didattica Login Documenti EN
Progetti in evidenza
INCIPIT
(Link esterno)

ISTAPCA
(1209 visite)

Fondo Europeo Pesca
(622 visite)

Euro-BioImaging
(Link esterno)

Fondazione Veronesi
(Link esterno)

LightDyNAmics
(1094 visite)

 INMiND
(1186 visite)

Instruct-IT
(Link esterno)

 PRIN
(1329 visite)

 eHealthNet
(1090 visite)

Ponrec
(1028 visite)

MFAG Grant
(1134 visite)

MERIT
(Link esterno)


Collegamenti

Contiene: [X]      Estesa     Autori: [X]  Tipo di lavoro: [X]   Data iniziale: Data finale: [X]      Sede: Affiliazione IBB     
    
[Pulisci modulo]


Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one (45 visite)

Supuran CT, Alterio V, Di Fiore A, D'Ambrosio K, Carta F, Monti SM, De Simone G

Med Res Rev (ISSN: 1098-1128electronic, 0198-6325linking), 2018 Sep; 38(6): 1799-1836.



Tipo di articolo: Journal Article, Review,

Impact factor: 8.29, Impact factor a 5 anni: 0

Url: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045199299&doi=10.1002%2fmed.21497&partnerID=40&md5=72453483d0ff3f153254038e15e7431d

Parole chiave: Antibodies, Carbonic Anhydrase Ix, Diagnostic Tools, Drugs, Hypoxic Tumors, Small Molecule Inhibitors, Antimetastatic Agent, Antineoplastic Agent, Carbonate Dehydratase Ix, Carboxylic Acid, Carboxylic Acid Derivative, Coumarin Derivative, Enzyme Inhibitor, Monoclonal Antibody, Nonsteroid Antiinflammatory Agent, Phenol, Phenol Derivative, Sulfonamide, Arthritis, Brain Ischemia, Cancer Stem Cell, Catalysis, Cell Invasion, Cell Migration, Cell Survival, Enzyme Inhibition, Enzyme Structure, Human, Metastasis, Nonhuman, Primary Tumor, Protein Expression, Review, Solid Malignant Neoplasm,

Affiliazioni:

*** IBB - CNR ***
Dipartimento Neurofarba, Sezione di Scienze Farmaceutiche e Nutraceutiche, Universita degli Studi di Firenze, Florence, Italy., Istituto di Biostrutture e Bioimmagini-CNR, Naples, Italy.,



Riferimenti:

Alterio, V., Di Fiore, A., D'Ambrosio, K., Supuran, C.T., De Simone, G., Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms (2012) Chem Rev, 112, pp. 4421-446

Zavada, J., Zavadova, Z., An unusual transmissible agent–MaTu (1991) Arch Virol, 118, pp. 189-197

Pastorekova, S., Zavadova, Z., Kostal, M., Babusikova, O., Zavada, J., A novel quasi-viral agent, MaTu, is a two-component system (1992) Virology, 187, pp. 620-626

Pastorek, J., Pastorekova, S., Callebaut, I., Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment (1994) Oncogene, 9, pp. 2877-2888

Opavsky, R., Pastorekova, S., Zelnik, V., Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships (1996) Genomics, 33, pp. 480-487

Monti, S.M., Supuran, C.T., De Simone, G., Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013) (2013) Expert Opin Ther Pat, 23, pp. 737-749

Supuran, C.T., Di Fiore, A., Alterio, V., Monti, S.M., De Simone, G., Recent advances in structural studies of the carbonic anhydrase family: the crystal structure of human CA IX and CA XIII (2010) Curr Pharm Des, 16, pp. 3246-3254

De Simone, G., Alterio, V., Supuran, C.T., Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors (2013) Expert Opin Drug Discov, 8, pp. 793-810

Supuran, C.T., How many carbonic anhydrase inhibition mechanisms exist (2016) J Enzyme Inhib Med Chem, 31, pp. 345-360

Supuran, C.T., Structure-based drug discovery of carbonic anhydrase inhibitors (2012) J Enzyme Inhib Med Chem, 27, pp. 759-772

Pacchiano, F., Carta, F., McDonald, P.C., Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis (2011) J Med Chem, 54, pp. 1896-1902

Lou, Y., McDonald, P.C., Oloumi, A., Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors (2011) Cancer Res, 71, pp. 3364-3376

Safety Study of SLC‒0111 in Subjects With Advanced Solid Tumours, , https://clinicaltrials.gov/ct2/show/study/NCT02215850?term=SLC_0111&rank=1, Available from, (accessed July 20, 2017)

Ariser, adjuvant RENCAREX immunotherapy phase III trial to study efficacy in non metastatic RCC, , https://clinicaltrials.gov/ct2/show/NCT00087022, Available from, (accessed July 20, 2017)

Divgi, C.R., Uzzo, R.G., Gatsonis, C., Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial (2013) J Clin Oncol, 31, pp. 187-194

Buanne, P., Renzone, G., Monteleone, F., Characterization of carbonic anhydrase IX interactome reveals proteins assisting its nuclear localization in hypoxic cells (2013) J Proteome Res, 12, pp. 282-292

Bryant, D.M., Stow, J.L., Nuclear translocation of cell-surface receptors: lessons from fibroblast growth factor (2005) Traffic, 6, pp. 947-954

Wingo, T., Tu, C., Laipis, P.J., Silverman, D.N., The catalytic properties of human carbonic anhydrase IX (2001) Biochem Biophys Res Commun, 288, pp. 666-669

Hilvo, M., Baranauskiene, L., Salzano, A.M., Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes (2008) J Biol Chem, 283, pp. 27799-27809

Innocenti, A., Pastorekova, S., Pastorek, J., Scozzafava, A., De Simone, G., Supuran, C.T., The proteoglycan region of the tumor-associated carbonic anhydrase isoform IX acts as anintrinsic buffer optimizing CO2 hydration at acidic pH values characteristic of solid tumors (2009) Bioorg Med Chem Lett, 19, pp. 5825-5828

Funderburgh, J.L., Keratan sulfate: structure, biosynthesis, and function (2000) Glycobiology, 10, pp. 951-958

Ditte, P., Dequiedt, F., Svastova, E., Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors (2011) Cancer Res, 71, pp. 7558-7567

Dorai, T., Sawczuk, I.S., Pastorek, J., Wiernik, P.H., Dutcher, J.P., The role of carbonic anhydrase IX overexpression in kidney cancer (2005) Eur J Cancer, 41, pp. 2935-2947

Alterio, V., Hilvo, M., Di Fiore, A., Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX (2009) Proc Natl Acad Sci U S A, 106, pp. 16233-16238

Leitans, J., Kazaks, A., Balode, A., Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX (2015) J Med Chem, 58, pp. 9004-9009

Mahon, B.P., Bhatt, A., Socorro, L., The structure of carbonic anhydrase IX is adapted for low-pH catalysis (2016) Biochemistry, 55, pp. 4642-4653

Domsic, J.F., Avvaru, B.S., Kim, C.U., Entrapment of carbon dioxide in the active site of carbonic anhydrase II (2008) J Biol Chem, 283, pp. 30766-30771

Maupin, C.M., McKenna, R., Silverman, D.N., Voth, G.A., Elucidation of the proton transport mechanism in human carbonic anhydrase II (2009) J Am Chem Soc, 131, pp. 7598-7608

Tu, C.K., Silverman, D.N., Forsman, C., Jonsson, B.H., Lindskog, S., Role of histidine 64 in the catalytic mechanism of human carbonic anhydrase II studied with a site-specific mutant (1989) Biochemistry, 28, pp. 7913-7918

Silverman, D.N., McKenna, R., Solvent-mediated proton transfer in catalysis by carbonic anhydrase (2007) Acc Chem Res, 40, pp. 669-675

Roy, A., Taraphder, S., Identification of proton-transfer pathways in human carbonic anhydrase II (2007) J Phys Chem B, 111, pp. 10563-10576

Fisher, S.Z., Maupin, C.M., Budayova-Spano, M., Atomic crystal and molecular dynamics simulation structures of human carbonic anhydrase II: insights into the proton transfer mechanism (2007) Biochemistry, 46, pp. 2930-2937

Pilka, E.S., Kochan, G., Oppermann, U., Yue, W.W., Crystal structure of the secretory isozyme of mammalian carbonic anhydrases CA VI: implications for biological assembly and inhibitor development (2012) Biochem Biophys Res Commun, 419, pp. 485-489

Whittington, D.A., Waheed, A., Ulmasov, B., Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells (2001) Proc Natl Acad Sci U S A, 98, pp. 9545-9550

Di Fiore, A., Capasso, C., De Luca, V., X-ray structure of the first `extremo-alpha-carbonic anhydrase', a dimeric enzyme from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1 (2013) Acta Crystallogr D Biol Crystallogr, 69, pp. 1150-1159

Zavadova, Z., Zavada, J., Carbonic anhydrase IX (CA IX) mediates tumor cell interactions with microenvironment (2005) Oncol Rep, 13, pp. 977-982

Svastova, E., Zilka, N., Zat'ovicova, M., Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin (2003) Exp Cell Res, 290, pp. 332-345

Stiti, M., Cecchi, A., Rami, M., Carbonic anhydrase inhibitor coated gold nanoparticles selectively inhibit the tumor-associated isoform IX over the cytosolic isozymes I and II (2008) J Am Chem Soc, 130, pp. 16130-16131

Menchise, V., De Simone, G., Alterio, V., Carbonic anhydrase inhibitors: stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II (2005) J Med Chem, 48, pp. 5721-5727

Stams, T., Nair, S.K., Okuyama, T., Waheed, A., Sly, W.S., Christianson, D.W., Crystal structure of the secretory form of membrane-associated human carbonic anhydrase IV at 2.8-A resolution (1996) Proc Natl Acad Sci U S A, 93, pp. 13589-13594

Alterio, V., Pan, P., Parkkila, S., The structural comparison between membrane-associated human carbonic anhydrases provides insights into drug design of selective inhibitors (2014) Biopolymers, 101, pp. 769-778

Supuran, C.T., Acetazolamide for the treatment of idiopathic intracranial hypertension (2015) Expert Rev Neurother, 15, pp. 851-856

Pastorekova, S., Parkkila, S., Parkkila, A.K., Carbonic anhydrase IX MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts (1997) Gastroenterology, 112, pp. 398-408

Saarnio, J., Parkkila, S., Parkkila, A.K., Immunohistochemistry of carbonic anhydrase isozyme IX (MN/CA IX) in human gut reveals polarized expression in the epithelial cells with the highest proliferative capacity (1998) J Histochem Cytochem, 46, pp. 497-504

Kaluz, S., Kaluzova, M., Liao, S.Y., Lerman, M., Stanbridge, E.J., Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: a one transcription factor (HIF-1) show (2009) Biochim Biophys Acta, 1795, pp. 162-172

Ilardi, G., Zambrano, N., Merolla, F., Histopathological determinants of tumor resistance: a special look to the immunohistochemical expression of carbonic anhydrase IX in human cancers (2014) Curr Med Chem, 21, pp. 1569-1582

Ivanov, S., Liao, S.Y., Ivanova, A., Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer (2001) Am J Pathol, 158, pp. 905-919

Ondriskova, E., Debreova, M., Pastorekova, S., Tumor-associated carbonic anhydrases IX and XII (2015) Carbonic Anhydrases as Biocatalysts: From Theory to Medical and Industrial Applications, pp. 169-206. , Supuran CT, De Simone G, eds., Amsterdam, the Netherlands, Elsevier

Gut, M.O., Parkkila, S., Vernerova, Z., Gastric hyperplasia in mice with targeted disruption of the carbonic anhydrase gene Car9 (2002) Gastroenterology, 123, pp. 1889-1903

Liao, S.Y., Aurelio, O.N., Jan, K., Zavada, J., Stanbridge, E.J., Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney (1997) Cancer Res, 57, pp. 2827-2831

Liao, S.Y., Brewer, C., Zavada, J., Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas (1994) Am J Pathol, 145, pp. 598-609

Chia, S.K., Wykoff, C.C., Watson, P.H., Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma (2001) J Clin Oncol, 19, pp. 3660-3668

Jonathan, R.A., Wijffels, K.I., Peeters, W., The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON (2006) Radiother Oncol, 79, pp. 288-297

Giatromanolaki, A., Koukourakis, M.I., Sivridis, E., Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer (2001) Cancer Res, 61, pp. 7992-7998

Vermylen, P., Roufosse, C., Burny, A., Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma (1999) Eur Respir J, 14, pp. 806-811

Turner, J.R., Odze, R.D., Crum, C.P., Resnick, M.B., MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker (1997) Hum Pathol, 28, pp. 740-744

Kowalewska, M., Radziszewski, J., Kulik, J., Detection of carbonic anhydrase 9-expressing tumor cells in the lymph nodes of vulvar carcinoma patients by RT-PCR (2005) Int J Cancer, 116, pp. 957-962

Hynninen, P., Vaskivuo, L., Saarnio, J., Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours (2006) Histopathology, 49, pp. 594-602

Kivela, A.J., Knuuttila, A., Rasanen, J., Carbonic anhydrase IX in malignant pleural mesotheliomas: a potential target for anti-cancer therapy (2013) Bioorg Med Chem, 21, pp. 1483-1488

Proescholdt, M.A., Mayer, C., Kubitza, M., Expression of hypoxia-inducible carbonic anhydrases in brain tumors (2005) Neuro Oncol, 7, pp. 465-475

Colpaert, C.G., Vermeulen, P.B., Fox, S.B., Harris, A.L., Dirix, L.Y., Van Marck, E.A., The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis (2003) Breast Cancer Res Treat, 81, pp. 137-147

Cleven, A.H., van Engeland, M., Wouters, B.G., de Bruine, A.P., Stromal expression of hypoxia regulated proteins is an adverse prognostic factor in colorectal carcinomas (2007) Cell Oncol, 29, pp. 229-240

Nakao, M., Ishii, G., Nagai, K., Prognostic significance of carbonic anhydrase IX expression by cancer-associated fibroblasts in lung adenocarcinoma (2009) Cancer, 115, pp. 2732-2743

Brockton, N., Dort, J., Lau, H., High stromal carbonic anhydrase IX expression is associated with decreased survival in P16-negative head-and-neck tumors (2011) Int J Radiat Oncol Biol Phys, 80, pp. 249-257

Brockton, N.T., Klimowicz, A.C., Bose, P., High stromal carbonic anhydrase IX expression is associated with nodal metastasis and decreased survival in patients with surgically-treated oral cavity squamous cell carcinoma (2012) Oral Oncol, 48, pp. 615-622

Fiaschi, T., Giannoni, E., Taddei, M.L., Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells (2013) Cell Cycle, 12, pp. 1791-1801

Lock, F.E., McDonald, P.C., Lou, Y., Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche (2013) Oncogene, 32, pp. 5210-5219

Kalavska, K., Cierna, Z., Chovanec, M., Prognostic value of intratumoral carbonic anhydrase IX expression in testicular germ cell tumors (2017) Oncol Lett, 13, pp. 2177-2185

Saenz-de-Santa-Maria, I., Bernardo-Castineira, C., Secades, P., Clinically relevant HIF-1alpha-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation (2017) Oncotarget, 8, pp. 13730-13746

Potter, C., Harris, A.L., Hypoxia inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target (2004) Cell Cycle, 3, pp. 164-167

Wykoff, C.C., Beasley, N.J., Watson, P.H., Hypoxia-inducible expression of tumor-associated carbonic anhydrases (2000) Cancer Res, 60, pp. 7075-7083

Nakazawa, M.S., Keith, B., Simon, M.C., Oxygen availability and metabolic adaptations (2016) Nat Rev Cancer, 16, pp. 663-673

Schofield, C.J., Ratcliffe, P.J., Signalling hypoxia by HIF hydroxylases (2005) Biochem Biophys Res Commun, 338, pp. 617-626

Kondo, K., The von Hippel-Lindau tumor suppressor gene (2001) Exp Cell Res, 264, pp. 117-125

Tafreshi, N.K., Lloyd, M.C., Bui, M.M., Gillies, R.J., Morse, D.L., Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases (2014) Subcell Biochem, 75, pp. 221-254

Mboge, M.Y., Mahon, B.P., McKenna, R., Frost, S.C., Carbonic Anhydrases: Role in pH Control and Cancer (2018) Metabolites, 8 (1). , https://www.ncbi.nlm.nih.gov/pubmed/29495652, pii

Swietach, P., Vaughan-Jones, R.D., Harris, A.L., Regulation of tumor pH and the role of carbonic anhydrase 9 (2007) Cancer Metastasis Rev, 26, pp. 299-310

Hulikova, A., Zat’ovicova, M., Svastova, E., Intact intracellular tail is critical for proper functioning of the tumor-associated, hypoxia-regulated carbonic anhydrase IX (2009) FEBS Lett, 583, pp. 3563-3568

Svastova, E., Witarski, W., Csaderova, L., Carbonic anhydrase IX interacts with bicarbonate transporters in lamellipodia and increases cell migration via its catalytic domain (2012) J Biol Chem, 287, pp. 3392-3402

Radvak, P., Repic, M., Svastova, E., Suppression of carbonic anhydrase IX leads to aberrant focal adhesion and decreased invasion of tumor cells (2013) Oncol Rep, 29, pp. 1147-1153

Chiche, J., Ilc, K., Laferriere, J., Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH (2009) Cancer Res, 69, pp. 358-368

Stubbs, M., McSheehy, P.M., Griffiths, J.R., Bashford, C.L., Causes and consequences of tumour acidity and implications for treatment (2000) Mol Med today, 6, pp. 15-19

Helmlinger, G., Sckell, A., Dellian, M., Forbes, N.S., Jain, R.K., Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism (2002) Clin Cancer Res, 8, pp. 1284-1291

Fukumura, D., Jain, R.K., Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize (2007) J Cell Biochem, 101, pp. 937-949

Raghunand, N., Gatenby, R.A., Gillies, R.J., Microenvironmental and cellular consequences of altered blood flow in tumours (2003) Br J Radiol, 76 (Spec No 1), pp. S11-S22

Svastova, E., Hulikova, A., Rafajova, M., Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH (2004) FEBS Lett, 577, pp. 439-445

Shin, H.J., Rho, S.B., Jung, D.C., Han, I.O., Oh, E.S., Kim, J.Y., Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion (2011) J Cell Sci, 124, pp. 1077-1087

Csaderova, L., Debreova, M., Radvak, P., The effect of carbonic anhydrase IX on focal contacts during cell spreading and migration (2013) Front Physiol, 4, p. 271

Buonanno, M., Langella, E., Zambrano, N., Disclosing the interaction of carbonic anhydrase IX with cullin-associated NEDD8-dissociated protein 1 by molecular modeling and integrated binding measurements (2017) ACS Chem Biol, 12, pp. 1460-1465

Swayampakula, M., McDonald, P.C., Vallejo, M., The interactome of metabolic enzyme carbonic anhydrase IX reveals novel roles in tumor cell migration and invadopodia/MMP14-mediated invasion (2017) Oncogene, 36, pp. 6244-6261

Oosterwijk, E., Ruiter, D.J., Hoedemaeker, P.J., Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney (1986) Int J Cancer, 38, pp. 489-494

Zatovicova, M., Jelenska, L., Hulikova, A., Monoclonal antibody G250 targeting CA: binding specificity, internalization and therapeutic effects in a non-renal cancer model (2014) Int J Oncol, 45, pp. 2455-2467

van Dijk, J., Zegveld, S.T., Fleuren, G.J., Warnaar, S.O., Localization of monoclonal antibody G250 and bispecific monoclonal antibody CD3/G250 in human renal-cell carcinoma xenografts: relative effects of size and affinity (1991) Int J Cancer, 48, pp. 738-743

Kranenborg, M.H., Boerman, O.C., de Weijert, M.C., Oosterwijk-Wakka, J.C., Corstens, F.H., Oosterwijk, E., The effect of antibody protein dose of anti-renal cell carcinoma monoclonal antibodies in nude mice with renal cell carcinoma xenografts (1997) Cancer, 80, pp. 2390-2397

Steffens, M.G., Oosterwijk, E., Kranenborg, M.H., In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations (1999) J Nucl Med, 40, pp. 829-836

Steffens, M.G., Kranenborg, M.H., Boerman, O.C., Tumor retention of 186Re-MAG3, 111In-DTPA and 125I labeled monoclonal antibody G250 in nude mice with renal cell carcinoma xenografts (1998) Cancer Biother Radiopharm, 13, pp. 133-139

Oosterwijk, E., Bander, N.H., Divgi, C.R., Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250 (1993) J Clin Oncol, 11, pp. 738-750

Divgi, C.R., Bander, N.H., Scott, A.M., Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma (1998) Clin Cancer Res, 4, pp. 2729-2739

Belldegrun, A.S., Chamie, K., Kloepfer, P., ARISER: a randomized double blind phase III study to evaluate adjuvant cG250 treatment versus placebo in patients with high-risk ccRCC: results and implications for adjuvant clinical trials (2013) J Clin Oncol, 31, p. 4507

Chrastina, A., Zavada, J., Parkkila, S., Biodistribution and pharmacokinetics of I-125-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma (2003) Int J Cancer, 105, pp. 873-881

Klatte, T., Seligson, D.B., Rao, J.Y., Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker (2009) Cancer, 115, pp. 1448-1458

Jensen, H.K., Nordsmark, M., Donskov, F., Marcussen, N., von der Maase, H., Immunohistochemical expression of carbonic anhydrase IX assessed over time and during treatment in renal cell carcinoma (2008) BJU Int, 101, pp. 41-44

Kral, V., Mader, P., Collard, R., Stabilization of antibody structure upon association to a human carbonic anhydrase IX epitope studied by X-ray crystallography, microcalorimetry, and molecular dynamics simulations (2008) Proteins, 71, pp. 1275-1287

Zat'ovicova, M., Tarabkova, K., Svastova, E., Monoclonal antibodies generated in carbonic anhydrase IX-deficient mice recognize different domains of tumour-associated hypoxia-induced carbonic anhydrase IX (2003) J Immunol Methods, 282, pp. 117-134

Zat’ovicova, M., Jelenska, L., Hulikova, A., Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain (2010) Curr Pharm Des, 16, pp. 3255-3263

Ahlskog, J.K., Schliemann, C., Marlind, J., Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours (2009) Br J Cancer, 101, pp. 645-657

Murri-Plesko, M.T., Hulikova, A., Oosterwijk, E., Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IX (2011) Eur J Pharmacol, 657, pp. 173-183

Supuran, C.T., Carbonic anhydrases: novel therapeutic applications for inhibitors and activators (2008) Nat Rev Drug Discov, 7, pp. 168-181

Neri, D., Supuran, C.T., Interfering with pH regulation in tumours as a therapeutic strategy (2011) Nat Rev Drug Discov, 10, pp. 767-777

Supuran, C.T., Advances in structure-based drug discovery of carbonic anhydrase inhibitors (2017) Expert Opin Drug Discov, 12, pp. 61-88

Vullo, D., Franchi, M., Gallori, E., Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides (2003) Bioorg Med Chem Lett, 13, pp. 1005-1009

Scozzafava, A., Menabuoni, L., Mincione, F., Briganti, F., Mincione, G., Supuran, C.T., Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring (1999) J Med Chem, 42, pp. 2641-2650

Scozzafava, A., Briganti, F., Mincione, G., Menabuoni, L., Mincione, F., Supuran, C.T., Carbonic anhydrase inhibitors: synthesis of water-soluble, aminoacyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route (1999) J Med Chem, 42, pp. 3690-3700

Ilies, M.A., Vullo, D., Pastorek, J., Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives (2003) J Med Chem, 46, pp. 2187-2196

Franchi, M., Vullo, D., Gallori, E., Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with lipophilic sulfonamides (2003) J Enzyme Inhib Med Chem, 18, pp. 333-338

Pastorekova, S., Casini, A., Scozzafava, A., Vullo, D., Pastorek, J., Supuran, C.T., Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX (2004) Bioorg Med Chem Lett, 14, pp. 869-873

Casey, J.R., Morgan, P.E., Vullo, D., Scozzafava, A., Mastrolorenzo, A., Supuran, C.T., Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX (2004) J Med Chem, 47, pp. 2337-2347

Garaj, V., Puccetti, L., Fasolis, G., Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties (2004) Bioorg Med Chem Lett, 14, pp. 5427-5433

Di Fiore, A., De Simone, G., Menchise, V., Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II (2005) Bioorg Med Chem Lett, 15, pp. 1937-1942

Cecchi, A., Hulikova, A., Pastorek, J., Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors (2005) J Med Chem, 48, pp. 4834-4841

Alterio, V., Vitale, R.M., Monti, S.M., Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX (2006) J Am Chem Soc, 128, pp. 8329-8335

DeSimone, G., Vitale, R.M., Di Fiore, A., Carbonic anhydrase inhibitors: hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX (2006) J Med Chem, 49, pp. 5544-5551

Wilkinson, B.L., Bornaghi, L.F., Houston, T.A., Innocenti, A., Supuran, C.T., Poulsen, S.A., A novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by “click-tailing” (2006) J Med Chem, 49, pp. 6539-6548

Smaine, F.Z., Winum, J.Y., Montero, J.L., Carbonic anhydrase inhibitors: selective inhibition of the extracellular, tumor-associated isoforms IX and XII over isozymes I and II with glycosyl-thioureido-sulfonamides (2007) Bioorg Med Chem Lett, 17, pp. 5096-5100

Guzel, O., Temperini, C., Innocenti, A., Scozzafava, A., Salman, A., Supuran, C.T., Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies (2008) Bioorg Med Chem Lett, 18, pp. 152-158

Rami, M., Winum, J.Y., Innocenti, A., Montero, J.L., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors: copper(II) complexes of polyamino-polycarboxylamido aromatic/heterocyclic sulfonamides are very potent inhibitors of the tumor-associated isoforms IX and XII (2008) Bioorg Med Chem Lett, 18, pp. 836-841

D'Ambrosio, K., Vitale, R.M., Dogne, J.M., Carbonic anhydrase inhibitors: bioreductive nitro-containing sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII (2008) J Med Chem, 51, pp. 3230-3237

Rami, M., Cecchi, A., Montero, J.L., Carbonic anhydrase inhibitors: design of membrane-impermeant copper(II) complexes of DTPA-, DOTA-, and TETA-tailed sulfonamides targeting the tumor-associated transmembrane isoform IX (2008) ChemMedChem, 3, pp. 1780-1788

Vomasta, D., Innocenti, A., Konig, B., Supuran, C.T., Carbonic anhydrase inhibitors: two-prong versus mono-prong inhibitors of isoforms I, II, IX, and XII exemplified by photochromic cis-1,2-alpha-dithienylethene derivatives (2009) Bioorg Med Chem Lett, 19, pp. 1283-1286

Carta, F., Maresca, A., Scozzafava, A., Vullo, D., Supuran, C.T., Carbonic anhydrase inhibitors. Diazenylbenzenesulfonamides are potent and selective inhibitors of the tumor-associated isozymes IX and XII over the cytosolic isoforms I and II (2009) Bioorg Med Chem, 17, pp. 7093-7099

Brzozowski, Z., Slawinski, J., Saczewski, F., Innocenti, A., Supuran, C.T., Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with 4-substituted 3-pyridinesulfonamides (2010) Eur J Med Chem, 45, pp. 2396-2404

Marques, S.M., Enyedy, E.A., Supuran, C.T., Krupenko, N.I., Krupenko, S.A., Santos, M.A., Pteridine-sulfonamide conjugates as dual inhibitors of carbonic anhydrases and dihydrofolate reductase with potential antitumor activity (2010) Bioorg Med Chem, 18, pp. 5081-5089

Buller, F., Steiner, M., Frey, K., Selection of carbonic anhydrase IX inhibitors from one million DNA-encoded compounds (2011) ACS Chem Biol, 6, pp. 336-344

Rami, M., Maresca, A., Smaine, F.Z., Sulfonamides incorporating boroxazolidone moieties are potent inhibitors of the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII (2011) Bioorg Med Chem Lett, 21, pp. 2975-2979

Carta, F., Garaj, V., Maresca, A., Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: solution and X-ray crystallographic studies (2011) Bioorg Med Chem, 19, pp. 3105-3119

Morris, J.C., Chiche, J., Grellier, C., Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors (2011) J Med Chem, 54, pp. 6905-6918

Groves, K., Bao, B., Zhang, J., Synthesis and evaluation of near-infrared fluorescent sulfonamide derivatives for imaging of hypoxia-induced carbonic anhydrase IX expression in tumors (2012) Bioorg Med Chem Lett, 22, pp. 653-657

Can, D., Spingler, B., Schmutz, P., [(Cp-R)M(CO)3] (M = Re or 99mTc) Arylsulfonamide, arylsulfamide, and arylsulfamate conjugates for selective targeting of human carbonic anhydrase IX (2012) Angew Chem Int Ed Engl, 51, pp. 3354-3357

Gieling, R.G., Babur, M., Mamnani, L., Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts (2012) J Med Chem, 55, pp. 5591-5600

Winum, J.Y., Carta, F., Ward, C., Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines (2012) Bioorg Med Chem Lett, 22, pp. 4681-4685

D'Ambrosio, K., Smaine, F.Z., Carta, F., De Simone, G., Winum, J.Y., Supuran, C.T., Development of potent carbonic anhydrase inhibitors incorporating both sulfonamide and sulfamide groups (2012) J Med Chem, 55, pp. 6776-6783

Guzel-Akdemir, O., Akdemir, A., Isik, S., Vullo, D., Supuran, C.T., o-Benzenedisulfonimido-sulfonamides are potent inhibitors of the tumor-associated carbonic anhydrase isoforms CA IX and CA XII (2013) Bioorg Med Chem, 21, pp. 1386-1391

Saada, M.C., Ombouma, J., Montero, J.L., Supuran, C.T., Winum, J.Y., Thiol-ene click chemistry for the synthesis of highly effective glycosyl sulfonamide carbonic anhydrase inhibitors (2013) Chem Commun (Camb), 49, pp. 5699-5701

Akdemir, A., Guzel-Akdemir, O., Scozzafava, A., Capasso, C., Supuran, C.T., Inhibition of tumor-associated human carbonic anhydrase isozymes IX and XII by a new class of substituted-phenylacetamido aromatic sulfonamides (2013) Bioorg Med Chem, 21, pp. 5228-5232

Rami, M., Dubois, L., Parvathaneni, N.K., Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides/sulfamides/sulfamates (2013) J Med Chem, 56, pp. 8512-8520

Sethi, K.K., Verma, S.M., Tanc, M., Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, IX and XII with benzene sulfonamides incorporating 4- and 3-nitrophthalimide moieties (2014) Bioorg Med Chem, 22, pp. 1586-1595

Khloya, P., Celik, G., SitaRam, Vullo, D., Supuran, C.T., Sharma, P.K., 4-Functionalized 1,3-diarylpyrazoles bearing benzenesulfonamide moiety as selective potent inhibitors of the tumor associated carbonic anhydrase isoforms IX and XII (2014) Eur J Med Chem, 76, pp. 284-290

Krall, N., Pretto, F., Decurtins, W., Bernardes, G.J., Supuran, C.T., Neri, D., A small-molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors (2014) Angew Chem Int Ed Engl, 53, pp. 4231-4235

Moeker, J., Peat, T.S., Bornaghi, L.F., Vullo, D., Supuran, C.T., Poulsen, S.A., Cyclic secondary sulfonamides: unusually good inhibitors of cancer-related carbonic anhydrase enzymes (2014) J Med Chem, 57, pp. 3522-3531

Rosatelli, E., Carotti, A., Ceruso, M., Supuran, C.T., Gioiello, A., Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors (2014) Bioorg Med Chem Lett, 24, pp. 3422-3425

Pala, N., Micheletto, L., Sechi, M., Carbonic anhydrase inhibition with benzenesulfonamides and tetrafluorobenzenesulfonamides obtained via click chemistry (2014) ACS Med Chem Lett, 5, pp. 927-930

Ghorab, M.M., Ceruso, M., Alsaid, M.S., Nissan, Y.M., Arafa, R.K., Supuran, C.T., Novel sulfonamides bearing pyrrole and pyrrolopyrimidine moieties as carbonic anhydrase inhibitors: synthesis, cytotoxic activity and molecular modeling (2014) Eur J Med Chem, 87, pp. 186-196

Mahon, B.P., Hendon, A.M., Driscoll, J.M., Saccharin: a lead compound for structure-based drug design of carbonic anhydrase IX inhibitors (2015) Bioorg Med Chem, 23, pp. 849-854

Dilworth, J.R., Pascu, S.I., Waghorn, P.A., Synthesis of sulfonamide conjugates of Cu(II), Ga(III), In(III), Re(V) and Zn(II) complexes: carbonic anhydrase inhibition studies and cellular imaging investigations (2015) Dalton Trans, 44, pp. 4859-4873

Ceruso, M., Antel, S., Scozzafava, A., Supuran, C.T., Synthesis and inhibition potency of novel ureido benzenesulfonamides incorporating GABA as tumor-associated carbonic anhydrase IX and XII inhibitors (2016) J Enzyme Inhib Med Chem, 31, pp. 205-211

Carta, F., Osman, S.M., Vullo, D., Poly(amidoamine) dendrimers with carbonic anhydrase inhibitory activity and antiglaucoma action (2015) J Med Chem, 58, pp. 4039-4045

Carta, F., Ferraroni, M., Scozzafava, A., Supuran, C.T., Fluorescent sulfonamide carbonic anhydrase inhibitors incorporating 1,2,3-triazole moieties: kinetic and X-ray crystallographic studies (2016) Bioorg Med Chem, 24, pp. 104-112

Cornelio, B., Laronze-Cochard, M., Ceruso, M., 4-Arylbenzenesulfonamides as human carbonic anhydrase inhibitors (hCAIs): synthesis by Pd nanocatalyst-mediated Suzuki-Miyaura reaction, enzyme inhibition, and X-ray crystallographic studies (2016) J Med Chem, 59, pp. 721-732

Lomelino, C.L., Mahon, B.P., McKenna, R., Carta, F., Supuran, C.T., Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111 (2016) Bioorg Med Chem, 24, pp. 976-981

Chandak, N., Ceruso, M., Supuran, C.T., Sharma, P.K., Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII (2016) Bioorg Med Chem, 24, pp. 2882-2886

Akocak, S., Alam, M.R., Shabana, A.M., PEGylated bis-sulfonamide carbonic anhydrase inhibitors can efficiently control the growth of several carbonic anhydrase IX-expressing carcinomas (2016) J Med Chem, 59, pp. 5077-5088

Mujumdar, P., Teruya, K., Tonissen, K.F., An unusual natural product primary sulfonamide: synthesis, carbonic anhydrase inhibition, and protein X-ray structures of psammaplin C (2016) J Med Chem, 59, pp. 5462-5470

Coviello, V., Marchi, B., Sartini, S., 1,2-Benzisothiazole derivatives bearing 4-, 5-, or 6-alkyl/arylcarboxamide moieties inhibit carbonic anhydrase isoform IX (CAIX) and cell proliferation under hypoxic conditions (2016) J Med Chem, 59, pp. 6547-6552

Nocentini, A., Vullo, D., Bartolucci, G., Supuran, C.T., N-Nitrosulfonamides: a new chemotype for carbonic anhydrase inhibition (2016) Bioorg Med Chem, 24, pp. 3612-3617

Gul, H.I., Mete, E., Eren, S.E., Sakagami, H., Yamali, C., Supuran, C.T., Designing, synthesis and bioactivities of 4-[3-(4-hydroxyphenyl)-5-aryl-4,5-dihydro-pyrazol-1-yl]benzenesulfonamides (2017) J Enzyme Inhib Med Chem, 32, pp. 169-175

Melis, C., Meleddu, R., Angeli, A., Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors (2017) J Enzyme Inhib Med Chem, 32, pp. 68-73

van Kuijk, S.J., Parvathaneni, N.K., Niemans, R., New approach of delivering cytotoxic drugs towards CAIX expressing cells: a concept of dual-target drugs (2017) Eur J Med Chem, 127, pp. 691-702

Nocentini, A., Ferraroni, M., Carta, F., Benzenesulfonamides incorporating flexible triazole moieties are highly effective carbonic anhydrase inhibitors: synthesis and kinetic, crystallographic, computational, and intraocular pressure lowering investigations (2016) J Med Chem, 59, pp. 10692-10704

Ivanova, J., Balode, A., Zalubovskis, R., 5-Substituted-benzylsulfanyl-thiophene-2-sulfonamides with effective carbonic anhydrase inhibitory activity: solution and crystallographic investigations (2017) Bioorg Med Chem, 25, pp. 857-863

Carta, F., Birkmann, A., Pfaff, T., Lead development of thiazolylsulfonamides with carbonic anhydrase inhibitory action (2017) J Med Chem, 60, pp. 3154-3164

Bragagni, M., Carta, F., Osman, S.M., AlOthman, Z., Supuran, C.T., Synthesis of an acridine orange sulfonamide derivative with potent carbonic anhydrase IX inhibitory action (2017) J Enzyme Inhib Med Chem, 32, pp. 701-706

Guzel, O., Maresca, A., Scozzafava, A., Salman, A., Balaban, A.T., Supuran, C.T., Carbonic anhydrase inhibitors. Synthesis of 2,4,6-trimethylpyridinium derivatives of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides acting as potent inhibitors of the tumor-associated isoform IX and XII (2009) Bioorg Med Chem Lett, 19, pp. 2931-2934

Bozdag, M., Ferraroni, M., Nuti, E., Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies (2014) Bioorg Med Chem, 22, pp. 334-340

Leitans, J., Sprudza, A., Tanc, M., 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies (2013) Bioorg Med Chem, 21, pp. 5130-5138

Carta, F., Vullo, D., Osman, S.M., AlOthman, Z., Supuran, C.T., Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs (2017) Bioorg Med Chem, 25, pp. 2569-2576

Angeli, A., Carta, F., Bartolucci, G., Supuran, C.T., Synthesis of novel acyl selenoureido benzensulfonamides as carbonic anhydrase I, II, VII and IX inhibitors (2017) Bioorg Med Chem, 25, pp. 3567-3573

Abdoli, M., Angeli, A., Bozdag, M., Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides (2017) J Enzyme Inhib Med Chem, 32, pp. 1071-1078

Angeli, A., Abdel-Aziz, A.A., Nocentini, A., El-Azab, A.S., Gratteri, P., Supuran, C.T., Synthesis and carbonic anhydrase inhibition of polycyclic imides incorporating N-benzenesulfonamide moieties (2017) Bioorg Med Chem, 25, pp. 5373-5379

Kumar, R., Sharma, V., Bua, S., Supuran, C.T., Sharma, P.K., Synthesis and biological evaluation of benzenesulphonamide-bearing 1,4,5-trisubstituted-1,2,3-triazoles possessing human carbonic anhydrase I, II, IV, and IX inhibitory activity (2017) J Enzyme Inhib Med Chem, 32, pp. 1187-1194

Angeli, A., Tanini, D., Peat, T.S., Discovery of new selenoureido analogues of 4-(4-fluorophenylureido)benzenesulfonamide as carbonic anhydrase inhibitors (2017) ACS Med Chem Lett, 8, pp. 963-968

Ramya, P.V.S., Angapelly, S., Angeli, A., Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors (2017) J Enzyme Inhib Med Chem, 32, pp. 1274-1281

Winum, J.Y., Pastorekova, S., Jakubickova, L., Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates (2005) Bioorg Med Chem Lett, 15, pp. 579-584

Colinas, P.A., Bravo, R.D., Vullo, D., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I and II, and extracellular isoforms IV, IX, and XII with sulfamides incorporating sugar moieties (2007) Bioorg Med Chem Lett, 17, pp. 5086-5090

Ombouma, J., Vullo, D., Dumy, P., Supuran, C.T., Winum, J.Y., Carbonic anhydrase glycoinhibitors belonging to the aminoxysulfonamide series (2015) ACS Med Chem Lett, 6, pp. 819-821

Vitale, R.M., Alterio, V., Innocenti, A., Carbonic anhydrase inhibitors. Comparison of aliphatic sulfamate/bis-sulfamate adducts with isozymes II and IX as a platform for designing tight-binding, more isoform-selective inhibitors (2009) J Med Chem, 52, pp. 5990-5998

Lopez, M., Paul, B., Hofmann, A., S-glycosyl primary sulfonamides: a new structural class for selective inhibition of cancer-associated carbonic anhydrases (2009) J Med Chem, 52, pp. 6421-6432

Kohler, K., Hillebrecht, A., Schulze Wischeler, J., Saccharin inhibits carbonic anhydrases: possible explanation for its unpleasant metallic aftertaste (2007) Angew Chem Int Ed Engl, 46, pp. 7697-7699

De Simone, G., Langella, E., Esposito, D., Insights into the binding mode of sulphamates and sulphamides to hCA II: crystallographic studies and binding free energy calculations (2017) J Enzyme Inhib Med Chem, 32, pp. 1002-1011

Alterio, V., Esposito, D., Monti, S.M., Supuran, C.T., De Simone, G., Crystal structure of the human carbonic anhydrase II adduct with 1-(4-sulfamoylphenyl-ethyl)-2,4,6-triphenylpyridinium perchlorate, a membrane-impermeant, isoform selective inhibitor (2018) J Enzyme Inhib Med Chem, 33, pp. 151-157

Pacchiano, F., Aggarwal, M., Avvaru, B.S., Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency (2010) Chem Commun (Camb), 46, pp. 8371-8373

Innocenti, A., Vullo, D., Scozzafava, A., Casey, J.R., Supuran, C., Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with carboxylates (2005) Bioorg Med Chem Lett, 15, pp. 573-578

Langella, E., D'Ambrosio, K., D'Ascenzio, M., A combined crystallographic and theoretical study explains the capability of carboxylic acids to adopt multiple binding modes in the active site of carbonic anhydrases (2016) Chemistry, 22, pp. 97-100

D'Ambrosio, K., Carradori, S., Monti, S.M., Out of the active site binding pocket for carbonic anhydrase inhibitors (2015) Chem Commun (Camb), 51, pp. 302-305

Maresca, A., Akyuz, G., Osman, S.M., AlOthman, Z., Supuran, C.T., Inhibition of mammalian carbonic anhydrase isoforms I-XIV with a series of phenolic acid esters (2015) Bioorg Med Chem, 23, pp. 7181-7188

Innocenti, A., Beyza Ozturk Sarikaya, S., Gulcin, I., Supuran, C.T., Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids (2010) Bioorg Med Chem, 18, pp. 2159-2164

Martin, D.P., Cohen, S.M., Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors (2012) Chem Commun (Camb), 48, pp. 5259-5261

Maresca, A., Temperini, C., Vu, H., Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors (2009) J Am Chem Soc, 131, pp. 3057-3062

Abdel-Aziz, A.A., El-Azab, A.S., Ceruso, M., Supuran, C.T., Carbonic anhydrase inhibitory activity of sulfonamides and carboxylic acids incorporating cyclic imide scaffolds (2014) Bioorg Med Chem Lett, 24, pp. 5185-5189

El-Azab, A.S., Abdel-Aziz, A.A., Ayyad, R.R., Ceruso, M., Supuran, C.T., Inhibition of carbonic anhydrase isoforms I, II, IV, VII and XII with carboxylates and sulfonamides incorporating phthalimide/phthalic anhydride scaffolds (2016) Bioorg Med Chem, 24, pp. 20-25

Barresi, E., Salerno, S., Marini, A.M., Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII (2016) Bioorg Med Chem, 24, pp. 921-927

Cvijetic, I.N., Tanc, M., Juranic, I.O., Verbic, T.Z., Supuran, C.T., Drakulic, B.J., 5-Aryl-1H-pyrazole-3-carboxylic acids as selective inhibitors of human carbonic anhydrases IX and XII (2015) Bioorg Med Chem, 23, pp. 4649-4659

Cadoni, R., Pala, N., Lomelino, C., Exploring heteroaryl-pyrazole carboxylic acids as human carbonic anhydrase XII inhibitors (2017) ACS Med Chem Lett, 8, pp. 941-946

Boztas, M., Cetinkaya, Y., Topal, M., Synthesis and carbonic anhydrase isoenzymes I, II, IX, and XII inhibitory effects of dimethoxybromophenol derivatives incorporating cyclopropane moieties (2015) J Med Chem, 58, pp. 640-650

Carradori, S., De Monte, C., D'Ascenzio, M., Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII: a new scaffold for designing isoform-selective inhibitors (2013) Bioorg Med Chem Lett, 23, pp. 6759-6763

Durdagi, S., Senturk, M., Ekinci, D., Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site (2011) Bioorg Med Chem, 19, pp. 1381-1389

Innocenti, A., Gulcin, I., Scozzafava, A., Supuran, C.T., Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV (2010) Bioorg Med Chem Lett, 20, pp. 5050-5053

Karioti, A., Ceruso, M., Carta, F., Bilia, A.R., Supuran, C.T., New natural product carbonic anhydrase inhibitors incorporating phenol moieties (2015) Bioorg Med Chem, 23, pp. 7219-7225

Scozzafava, A., Passaponti, M., Supuran, C.T., Gulcin, I., Carbonic anhydrase inhibitors: guaiacol and catechol derivatives effectively inhibit certain human carbonic anhydrase isoenzymes (hCA I, II, IX and XII) (2015) J Enzyme Inhib Med Chem, 30, pp. 586-591

Yamali, C., Gul, H.I., Sakagami, H., Supuran, C.T., Synthesis and bioactivities of halogen bearing phenolic chalcones and their corresponding bis Mannich bases (2016) J Enzyme Inhib Med Chem, 31, pp. 125-131

Abellan-Flos, M., Tanc, M., Supuran, C.T., Vincent, S.P., Exploring carbonic anhydrase inhibition with multimeric coumarins displayed on a fullerene scaffold (2015) Org Biomol Chem, 13, pp. 7445-7451

Bonneau, A., Maresca, A., Winum, J.Y., Supuran, C.T., Metronidazole-coumarin conjugates and 3-cyano-7-hydroxy-coumarin act as isoform-selective carbonic anhydrase inhibitors (2013) J Enzyme Inhib Med Chem, 28, pp. 397-401

Bozdag, M., Alafeefy, A.M., Altamimi, A.M., Vullo, D., Carta, F., Supuran, C.T., Coumarins and other fused bicyclic heterocycles with selective tumor-associated carbonic anhydrase isoforms inhibitory activity (2017) Bioorg Med Chem, 25, pp. 677-683

Bua, S., Di Cesare Mannelli, L., Vullo, D., Design and synthesis of novel nonsteroidal anti-inflammatory drugs and carbonic anhydrase inhibitors hybrids (NSAIDs-CAIs) for the treatment of rheumatoid arthritis (2017) J Med Chem, 60, pp. 1159-1170

Davis, R.A., Vullo, D., Maresca, A., Supuran, C.T., Poulsen, S.A., Natural product coumarins that inhibit human carbonic anhydrases (2013) Bioorg Med Chem, 21, pp. 1539-1543

Kucukbay, F.Z., Kucukbay, H., Tanc, M., Supuran, C.T., Synthesis and carbonic anhydrase inhibitory properties of amino acid: coumarin/quinolinone conjugates incorporating glycine, alanine and phenylalanine moieties (2016) J Enzyme Inhib Med Chem, 31, pp. 1198-1202

Nocentini, A., Carta, F., Ceruso, M., Bartolucci, G., Supuran, C.T., Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII (2015) Bioorg Med Chem, 23, pp. 6955-6966

Sharma, A., Tiwari, M., Supuran, C.T., Novel coumarins and benzocoumarins acting as isoform-selective inhibitors against the tumor-associated carbonic anhydrase IX (2014) J Enzyme Inhib Med Chem, 29, pp. 292-296

Touisni, N., Maresca, A., McDonald, P.C., Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors (2011) J Med Chem, 54, pp. 8271-8277

Vullo, D., Isik, S., Bozdag, M., Carta, F., Supuran, C.T., 7-Amino-3,4-dihydro-1H-quinolin-2-one, a compound similar to the substituted coumarins, inhibits alpha-carbonic anhydrases without hydrolysis of the lactam ring (2015) J Enzyme Inhib Med Chem, 30, pp. 773-777

Grandane, A., Tanc, M., Di Cesare Mannelli, L., 6-Substituted sulfocoumarins are selective carbonic anhdydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells (2015) J Med Chem, 58, pp. 3975-3983

Nocentini, A., Ceruso, M., Carta, F., Supuran, C.T., 7-Aryl-triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrase IX and XII (2016) J Enzyme Inhib Med Chem, 31, pp. 1226-1233

Pustenko, A., Stepanovs, D., Zalubovskis, R., 3H-1,2-benzoxathiepine 2,2-dioxides: a new class of isoform-selective carbonic anhydrase inhibitors (2017) J Enzyme Inhib Med Chem, 32, pp. 767-775

Tanc, M., Carta, F., Bozdag, M., Scozzafava, A., Supuran, C.T., 7-Substituted-sulfocoumarins are isoform-selective, potent carbonic anhydrase II inhibitors (2013) Bioorg Med Chem, 21, pp. 4502-4510

Tars, K., Vullo, D., Kazaks, A., Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases (2013) J Med Chem, 56, pp. 293-300

Falsini, M., Squarcialupi, L., Catarzi, D., 3-Hydroxy-1H-quinazoline-2,4-dione as a new scaffold to develop potent and selective inhibitors of the tumor-associated carbonic anhydrases IX and XII (2017) J Med Chem, 60, pp. 6428-6439

Liu, F., Martin-Mingot, A., Lecornue, F., Carbonic anhydrases inhibitory effects of new benzenesulfonamides synthesized by using superacid chemistry (2012) J Enzyme Inhib Med Chem, 27, pp. 886-891

Compain, G., Martin-Mingot, A., Maresca, A., Thibaudeau, S., Supuran, C.T., Superacid synthesis of halogen containing N-substituted-4-aminobenzene sulfonamides: new selective tumor-associated carbonic anhydrase inhibitors (2013) Bioorg Med Chem, 21, pp. 1555-1563

Metayer, B., Mingot, A., Vullo, D., Supuran, C.T., Thibaudeau, S., New superacid synthesized (fluorinated) tertiary benzenesulfonamides acting as selective hCA IX inhibitors: toward a new mode of carbonic anhydrase inhibition by sulfonamides (2013) Chem Commun (Camb), 49, pp. 6015-6017

Metayer, B., Martin-Mingot, A., Vullo, D., Supuran, C.T., Thibaudeau, S., Superacid synthesized tertiary benzenesulfonamides and benzofuzed sultams act as selective hCA IX inhibitors: toward understanding a new mode of inhibition by tertiary sulfonamides (2013) Org Biomol Chem, 11, pp. 7540-7549

Le Darz, A., Mingot, A., Bouazza, F., Fluorinated pyrrolidines and piperidines incorporating tertiary benzenesulfonamide moieties are selective carbonic anhydrase II inhibitors (2015) J Enzyme Inhib Med Chem, 30, pp. 737-745

D'Ascenzio, M., Carradori, S., De Monte, C., Secci, D., Ceruso, M., Supuran, C.T., Design, synthesis and evaluation of N-substituted saccharin derivatives as selective inhibitors of tumor-associated carbonic anhydrase XII (2014) Bioorg Med Chem, 22, pp. 1821-1831

De Monte, C., Carradori, S., Secci, D., Cyclic tertiary sulfamates: selective inhibition of the tumor-associated carbonic anhydrases IX and XII by N- and O-substituted acesulfame derivatives (2014) Eur J Med Chem, 84, pp. 240-246

Carradori, S., Mollica, A., Ceruso, M., New amide derivatives of probenecid as selective inhibitors of carbonic anhydrase IX and XII: biological evaluation and molecular modelling studies (2015) Bioorg Med Chem, 23, pp. 2975-2981

Mollica, A., Costante, R., Akdemir, A., Exploring new probenecid-based carbonic anhydrase inhibitors: synthesis, biological evaluation and docking studies (2015) Bioorg Med Chem, 23, pp. 5311-5318

D'Ascenzio, M., Guglielmi, P., Carradori, S., Open saccharin-based secondary sulfonamides as potent and selective inhibitors of cancer-related carbonic anhydrase IX and XII isoforms (2017) J Enzyme Inhib Med Chem, 32, pp. 51-59

Parkkila, S., Innocenti, A., Kallio, H., Hilvo, M., Scozzafava, A., Supuran, C.T., The protein tyrosine kinase inhibitors imatinib and nilotinib strongly inhibit several mammalian alpha-carbonic anhydrase isoforms (2009) Bioorg Med Chem Lett, 19, pp. 4102-4106

Dubois, L., Peeters, S., Lieuwes, N.G., Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation (2011) Radiother Oncol, 99, pp. 424-431

Ward, C., Meehan, J., Mullen, P., Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models (2015) Oncotarget, 6, pp. 24856-24870

Meehan, J., Ward, C., Turnbull, A., Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells (2017) Oncotarget, 8, pp. 42857-42875

Andreucci, E., Peppicelli, S., Carta, F., Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis (2017) J Mol Med (Berl), 95, pp. 1341-1353

Gieling, R.G., Parker, C.A., De Costa, L.A., Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cells in vitro (2013) J Enzyme Inhib Med Chem, 28, pp. 360-369

Bryant, J.L., Gieling, R.G., Meredith, S.L., Novel carbonic anhydrase IX-targeted therapy enhances the anti-tumour effects of cisplatin in small cell lung cancer (2018) Int J Cancer, 142, pp. 191-201

Logsdon, D.P., Grimard, M., Luo, M., Regulation of HIF1alpha under hypoxia by APE1/Ref-1 impacts CA9 expression: dual targeting in patient-derived 3D pancreatic cancer models (2016) Mol Cancer Ther, 15, pp. 2722-2732

Dubois, L., Douma, K., Supuran, C.T., Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors (2007) Radiother Oncol, 83, pp. 367-373

Dubois, L., Lieuwes, N.G., Maresca, A., Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model (2009) Radiother Oncol, 92, pp. 423-428

Akurathi, V., Dubois, L., Lieuwes, N.G., Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in vivo visualization of carbonic anhydrase IX expression in tumor hypoxia (2010) Nucl Med Biol, 37, pp. 557-564

Peeters, S.G., Dubois, L., Lieuwes, N.G., [(18)F]VM4-037 MicroPET imaging and biodistribution of two in vivo CAIX-expressing tumor models (2015) Mol Imaging Biol, 17, pp. 615-619

Pan, J., Lau, J., Mesak, F., Synthesis and evaluation of 18F-labeled carbonic anhydrase IX inhibitors for imaging with positron emission tomography (2014) J Enzyme Inhib Med Chem, 29, pp. 249-255

Lau, J., Liu, Z., Lin, K.S., Trimeric radiofluorinated sulfonamide derivatives to achieve in vivo selectivity for carbonic anhydrase IX-targeted PET imaging (2015) J Nucl Med, 56, pp. 1434-1440

Lau, J., Zhang, Z., Jenni, S., PET imaging of carbonic anhydrase IX expression of HT-29 tumor xenograft mice with (68)Ga-labeled benzenesulfonamides (2016) Mol Pharm, 13, pp. 1137-1146

Sneddon, D., Niemans, R., Bauwens, M., Synthesis and in vivo biological evaluation of (68)Ga-labeled carbonic anhydrase IX targeting small molecules for positron emission tomography (2016) J Med Chem, 59, pp. 6431-6443

Zhang, Z., Lau, J., Zhang, C., Design, synthesis and evaluation of 18F-labeled cationic carbonic anhydrase IX inhibitors for PET imaging (2017) J Enzyme Inhib Med Chem, 32, pp. 722-730

Margheri, F., Ceruso, M., Carta, F., Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium (2016) J Enzyme Inhib Med Chem, 31, pp. 60-63



Human carbonic anhydrase (CA) IX is a tumor-associated protein, since it is scarcely present in normal tissues, but highly overexpressed in a large number of solid tumors, where it actively contributes to survival and metastatic spread of tumor cells. Due to these features, the characterization of its biochemical, structural, and functional features for drug design purposes has been extensively carried out, with consequent development of several highly selective small molecule inhibitors and monoclonal antibodies to be used for different purposes. Aim of this review is to provide a comprehensive state-of-the-art of studies performed on this enzyme, regarding structural, functional, and biomedical aspects, as well as the development of molecules with diagnostic and therapeutic applications for cancer treatment. A brief description of additional pharmacologic applications for CA IX inhibition in other diseases, such as arthritis and ischemia, is also provided. © 2018 Wiley Periodicals, Inc.
    Monoclonal Antibodies for therapeutic and diagnostic applications

Contiene: [X]      Estesa     Autori: [X]  Tipo di lavoro: [X]   Data iniziale: Data finale: [X]      Sede: Affiliazione IBB     
    
[Pulisci modulo]


Langella E, Buonanno M, Vullo D, Dathan N, Leone M, Supuran C, De Simone G, Monti SM
* Biochemical, biophysical and molecular dynamics studies on the proteoglycan-like domain of carbonic anhydrase IX (87 visite)
Cell Mol Life Sci, 2018 Sep; 75: 3283-3296.
Impact Factor: 6.721
Dettagli    Esporta in BibTeX    Esporta in EndNote

Mishra CB, Kumari S, Angeli A, Bua S, Buonanno M, Monti SM, Tiwari M, Supuran CT
* Discovery of potent anti-convulsant carbonic anhydrase inhibitors: Design, synthesis, in vitro and in vivo appraisal (12 visite)
Eur J Med Chem (ISSN: 0223-5234linking, 1768-3254electronic), 2018 Aug 5; 156: 430-443.
Impact Factor: 4.816
Dettagli    Esporta in BibTeX    Esporta in EndNote

Della Pepa R, Cerchione C, Pugliese N, Colicchio R, Salvatore P, Sirignano C, Soscia E, Pagano L, Sanguinetti M, Pane F, Picardi M
* Diagnostic-driven antifungal approach in neutropenic patients at high risk for chronic disseminated candidiasis: preliminary observations on the role of 1, 3-ß-D-glucan antigenemia and multiphasic contrast-enhanced computed tomography (29 visite)
Supportive Care Cancer (ISSN: 0941-4355), 2018 Jun; 26(6): 1691-1694.
Impact Factor: 2.676
Dettagli    Esporta in BibTeX    Esporta in EndNote

De Simone G
* Targeted treatment of anaerobic cancer. Patent evaluation of US2016279084 and US2017056350 (12 visite)
Expert Opinion On Therapeutic Patents (ISSN: 1744-7674electronic, 1354-3776linking), 2018 Jun; N/D: 1-6.
Impact Factor: 4.626
Dettagli    Esporta in BibTeX    Esporta in EndNote

Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L
* Combined HAT/EZH2 modulation leads to cancer-selective cell death (47 visite)
Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646.
Impact Factor: 5.008
Dettagli    Esporta in BibTeX    Esporta in EndNote

Di Menna L, Joffe ME, Iacovelli L, Orlando R, Lindsley CW, Mairesse J, Gressèns P, Cannella M, Caraci F, Copani A, Bruno V, Battaglia G, Conn PJ, Nicoletti F
* Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system (75 visite)
Neuropharm (ISSN: 0028-3908linking, 1873-7064electronic), 2018 Jan; 128: 301-313.
Impact Factor: 3.383
Dettagli    Esporta in BibTeX    Esporta in EndNote

Brancaccio D, Diana D, Di Maro S, Di Leva FS, Tomassi S, Fattorusso R, Russo L, Scala S, Trotta AM, Portella L, Novellino E, Marinelli L, Carotenuto A
* Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer Cells (3 visite)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2018; 61(7): 2910-2923.
Impact Factor: 5.207
Dettagli    Esporta in BibTeX    Esporta in EndNote

Caraci F, Nicoletti F, Copani A
* Metabotropic glutamate receptors: the potential for therapeutic applications in Alzheimer's disease (68 visite)
Curr Opin Pharmacol (ISSN: 1471-4973electronic, 1471-4892linking), 2017 Dec 23; 38: 1-7.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Comegna D, Zannetti A, Del Gatto A, De Paola I, Russo L, Di Gaetano S, Liguoro A, Capasso D, Saviano M, Zaccaro L
* Chemical Modification for Proteolytic Stabilization of the Selective alphavbeta3 Integrin RGDechi Peptide: in Vitro and in Vivo Activities on Malignant Melanoma Cells (332 visite) (PDF 81 visite)
J Med Chem (ISSN: 1520-4804electronic, 0022-2623linking, 0022-2623print), 2017 Dec 14; 60(23): 9874-9884.
Impact Factor: 5.207
Dettagli    Esporta in BibTeX    Esporta in EndNote

Maglio O, Costanzo S, Cercola R, Zambrano G, Mauro M, Battaglia R, Ferrini G, Nastri F, Pavone V, Lombardi A
* A Quartz Crystal Microbalance Immunosensor for Stem Cell Selection and Extraction (60 visite) (PDF 48 visite)
Sensors (ISSN: 1424-8220electronic, 1424-8220linking, 1424-3210), 2017 Nov 28; 17(12): N/D-N/D.
Impact Factor: 2.048
Dettagli    Esporta in BibTeX    Esporta in EndNote

Berisio R, Squeglia F, Ruggiero A
* Editorial: Molecular Scenarios Behind Infectious Diseases (87 visite)
Curr Med Chem (ISSN: 1875-533xelectronic, 0929-8673linking), 2017 Nov 24; 24(36): 3939-3941.
Impact Factor: 3.249
Dettagli    Esporta in BibTeX    Esporta in EndNote

Marchiori MF, Riul TB, Oliveira Bortot L, Andrade P, Junqueira GG, Foca G, Doti N, Ruvo M, Dias-baruffi M, Carvalho I, Campo VL
* Binding of triazole-linked galactosyl arylsulfonamides to galectin-3 affects Trypanosoma cruzi cell invasion (54 visite)
Bioorg Med Chem (ISSN: 1464-3391electronic, 0968-0896linking), 2017 Nov 1; 25(21): 6049-6059.
Impact Factor: 2.822
Dettagli    Esporta in BibTeX    Esporta in EndNote

Roviello GN, Iannitti R, Roviello V, Palumbo R, Simonyan H, Vicidomini C
* Synthesis and biological evaluation of a novel Amadori compound (103 visite)
Amino Acids (ISSN: 0939-4451, 1438-2199, 1438-2199electronic), 2017 Nov; 49(2): 327-335.
Impact Factor: 3.196
Dettagli    Esporta in BibTeX    Esporta in EndNote

Calvanese L, Foca A, Sandomenico A, Foca G, Caporale A, Doti N, Iaccarino E, Leonardi A, D'Auria G, Ruvo M, Falcigno L
* Structural insights into the interaction of a monoclonal antibody and Nodal peptides by STD-NMR spectroscopy (152 visite)
Bioorg Med Chem (ISSN: 1464-3391electronic, 0968-0896linking), 2017 Oct 28; N/D: N/D-N/D.
Impact Factor: 2.93
Dettagli    Esporta in BibTeX    Esporta in EndNote

Oliveri V, Lanza V, Milardi D, Viale M, Maric I, Sgarlata C, Vecchio G
* Amino- and chloro-8-hydroxyquinolines and their copper complexes as proteasome inhibitors and antiproliferative agents (56 visite)
Metallomics (ISSN: 1756-591xelectronic, 1756-5901linking), 2017 Oct 18; 9(10): 1439-1446.
Impact Factor: 4.099
Dettagli    Esporta in BibTeX    Esporta in EndNote

Deplano A, Morgillo CM, Demurtas M, Bjorklund E, Cipriano M, Svensson M, Hashemian S, Smaldone G, Pedone E, Luque FJ, Cabiddu MG, Novellino E, Fowler CJ, Catalanotti B, Onnis V
* Novel propanamides as fatty acid amide hydrolase inhibitors (62 visite)
Eur J Med Chem (ISSN: 1768-3254electronic, 0223-5234linking), 2017 Aug 18; 136: 523-542.
Impact Factor: 4.519
Dettagli    Esporta in BibTeX    Esporta in EndNote

Platella C, Guida S, Bonmassar L, Aquino A, Bonmassar E, Ravagnan G, Montesarchio D, Roviello GN, Musumeci D, Fuggetta MP
* Antitumour activity of resveratrol on human melanoma cells: a possible mechanism related to its interaction with malignant cell telomerase (92 visite)
Biochim Biophys Acta (ISSN: 0006-3002print, 0006-3002linking, 0005-2728), 2017 Aug 02; 1861(11PtA): 2843-2851.
Impact Factor: 4.9
Dettagli    Esporta in BibTeX    Esporta in EndNote

Picone D, Donnarumma F, Ferraro G, Gotte G, Fagagnini A, Butera G, Donadelli M, Merlino A
* A comparison study on RNase A oligomerization induced by cisplatin, carboplatin and oxaliplatin (60 visite)
J Chem Res (ISSN: 1873-3344electronic, 0162-0134linking, 0162-0134print), 2017 Aug; 173: 105-112.
Impact Factor: 3.317
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gallicchio R, Nardelli A, Venetucci A, Capacchione D, Pelagalli A, Sirignano C, Mainenti P, Pedicini P, Guglielmi G, Storto G
* F-18 FDG PET/CT metabolic tumor volume predicts overall survival in patients with disseminated epithelial ovarian cancer (63 visite)
Eur J Radiol (ISSN: 0720-048x), 2017 Aug; 93: 107-113.
Impact Factor: 2.462
Dettagli    Esporta in BibTeX    Esporta in EndNote

Tomasello MF, Nardon C, Lanza V, Di Natale G, Pettenuzzo N, Salmaso S, Milardi D, Caliceti P, Pappalardo G, Fregona D
* New comprehensive studies of a gold(III) Dithiocarbamate complex with proven anticancer properties: Aqueous dissolution with cyclodextrins, pharmacokinetics and upstream inhibition of the ubiquitin-proteasome pathway (103 visite)
Eur J Med Chem (ISSN: 1768-3254electronic, 0223-5234linking), 2017 Jun 19; 138: 115-127.
Impact Factor: 4.519
Dettagli    Esporta in BibTeX    Esporta in EndNote

Roviello GN, Iannitti R, Palumbo R, Simonyan H, Vicidomini C, Roviello V
* Lac-L-TTA, a novel lactose-based amino acid-sugar conjugate for anti-metastatic applications (73 visite)
Amino Acids (ISSN: 1438-2199electronic, 0939-4451linking), 2017 May 06; 49(8): 1347-1353.
Impact Factor: 3.173
Dettagli    Esporta in BibTeX    Esporta in EndNote

Platella C, Riccardi C, Montesarchio D, Roviello GN, Musumeci D
* G-quadruplex-based aptamers against protein targets in therapy and diagnostics (80 visite)
Biochimica Et Biophysica Acta (ISSN: 0304-4165linking), 2017 May; 1861(5PtB): 1429-1447.
Impact Factor: 5.083
Dettagli    Esporta in BibTeX    Esporta in EndNote

Buonanno M, Langella E, Zambrano N, Succoio M, Sasso E, Alterio V, Di Fiore A, Sandomenico A, Supuran CT, Scaloni A, Monti SM, De Simone G
* Disclosing the Interaction of Carbonic Anhydrase IX with Cullin-Associated NEDD8-Dissociated Protein 1 by Molecular Modeling and Integrated Binding Measurements (87 visite)
Acs Chem Biol (ISSN: 1554-8937electronic, 1554-8929linking), 2017 Apr 19; N/D: N/D-N/D.
Impact Factor: 4.995
Dettagli    Esporta in BibTeX    Esporta in EndNote

Mishra CB, Kumari S, Angeli A, Monti SM, Buonanno M, Tiwari M, Supuran CT
* Discovery of Benzenesulfonamides with Potent Human Carbonic Anhydrase Inhibitory and Effective Anticonvulsant Action: Design, Synthesis, and Pharmacological Assessment (69 visite)
J Med Chem (ISSN: 1520-4804electronic, 0022-2623linking, 0022-2623print), 2017 Mar 23; 60(6): 2456-2469.
Impact Factor: 6.259
Dettagli    Esporta in BibTeX    Esporta in EndNote

Leiria Campo V, Riul TB, Oliveira Bortot L, Martins-teixeira MB, Fiori Marchiori M, Iaccarino E, Ruvo M, Dias-baruffi M, Carvalho I
* A Synthetic MUC1 Glycopeptide Bearing betaGalNAc-Thr as a Tn Antigen Isomer Induces the Production of Antibodies against Tumor Cells (56 visite)
Chembiochem (ISSN: 1439-7633electronic, 1439-4227linking), 2017 Mar 16; 18(6): 527-538.
Impact Factor: 3.322
Dettagli    Esporta in BibTeX    Esporta in EndNote

Segreto S, Fonti R, Ottaviano M, Pellegrino S, Pace L, Damiano V, Palmieri G, Del Vecchio S
* Evaluation of metabolic response with (18)F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors (60 visite)
Cancer Imaging (ISSN: 1470-7330electronic, 1470-7330linking), 2017 Mar 7; 17(1): 10-10.
Impact Factor: 1.286
Dettagli    Esporta in BibTeX    Esporta in EndNote

Martínez-fernández L, Granucci G, Pollum M, Crespo-hernández CE, Persico M, Corral I
* Decoding the Molecular Basis for the Population Mechanism of the Triplet Phototoxic Precursors in UVA Light-Activated Pyrimidine Anticancer Drugs (3 visite)
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2017; 23(11): 2619-2627.
Impact Factor: 5.476
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sandomenico A, Focà A, Sanguigno L, Caporale A, Focà G, Pignalosa A, Corvino G, Caragnano A, Beltrami AP, Antoniali G, Tell G, Leonardi A, Ruvo M
* Monoclonal antibodies against pools of mono- and polyacetylated peptides selectively recognize acetylated lysines within the context of the original antigen (113 visite) (PDF 128 visite)
Medicine Research And Experimental (ISSN: 1942-0862, 1942-0870e), 2016 Aug; 8: 1575-1589.
Impact Factor: 4.881
Dettagli    Esporta in BibTeX    Esporta in EndNote

Quero G, Consales M, Severino R, Vaiano P, Boniello A, Sandomenico A, Ruvo M, Borriello A, Diodato L, Zuppolini S, Giordano M, Nettore IC, Mazzarella C, Colao A, Macchia PE, Santorelli F, Cutolo A, Cusano A
* Long period fiber grating nano-optrode for cancer biomarker detection (111 visite) (PDF 124 visite)
Biosens Bioelectron (ISSN: 1873-4235electronic, 0956-5663linking), 2016 Feb 13; 80: 590-600.
Impact Factor: 7.78
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sandomenico A, Leonardi A, Berisio R, Sanguigno L, Foca G, Foca A, Ruggiero A, Doti N, Muscariello L, Barone D, Farina C, Owsianka A, Vitagliano L, Patel AH, Ruvo M
* Generation and characterization of monoclonal antibodies against a cyclic variant of Hepatitis C Virus E2 epitope 412-422 (138 visite) (PDF 102 visite)
J Virol (ISSN: 1098-5514electronic, 0022-538xlinking), 2016 Jan 27; 90(7): 3745-3759.
Impact Factor: 4.663
Dettagli    Esporta in BibTeX    Esporta in EndNote

Langella E, D'Ambrosio K, D'Ascenzio M, Carradori S, Monti SM, Supuran CT, De Simone G
* A Combined Crystallographic and Theoretical Study Explains the Capability of Carboxylic Acids to Adopt Multiple Binding Modes in the Active Site of Carbonic Anhydrases (115 visite)
Chemistry (ISSN: 1521-3765electronic, 0947-6539linking), 2016 Jan 4; 22(1): 97-100.
Impact Factor: 5.317
Dettagli    Esporta in BibTeX    Esporta in EndNote

Bogdanovich S, Kim Y, Mizutani T, Yasuma R, Tudisco L, Cicatiello V, Bastos-carvalho A, Kerur N, Hirano Y, Baffi JZ, Tarallo V, Li S, Yasuma T, Arpitha P, Fowler BJ, Wright CB, Apicella I, Greco A, Brunetti A, Ruvo M, Sandomenico A, Nozaki M, Ijima R, Kaneko H, Ogura Y, Terasaki H, Ambati BK, Leusen JH, Langdon WY, Clark MR, Armour KL, Bruhns P, Verbeek JS, Gelfand BD, De Falco S, Ambati J
* Human IgG1 antibodies suppress angiogenesis in a target-independent manner (272 visite)
Signal Transduct Target Ther (ISSN: 2059-3635print), 2016; 1: N/D-N/D.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Larobina M, Nappi C, Gaudieri V, Cuocolo A
* Instrumentation (4 visite)
Pet Ct And Pet Mri In Neurology (ISSN: 9783-3193161479783319316123), 2016; N/D: 13-21.
Impact Factor:
Dettagli    Esporta in BibTeX    Esporta in EndNote

Palladino P, Aura AM, Spoto G
* Surface plasmon resonance for the label-free detection of Alzheimer's β-amyloid peptide aggregation (161 visite)
Analytical And Bioanalytical Chemistry (ISSN: 1618-2642), 2016; 408(3): 849-854.
Impact Factor: 3.431
Dettagli    Esporta in BibTeX    Esporta in EndNote

Strizzi L, Sandomenico A, Margaryan NV, Foca A, Sanguigno L, Bodenstine TM, Chandler GS, Reed DW, Gilgur A, Seftor EA, Seftor RE, Khalkhali-ellis Z, Leonardi A, Ruvo M, Hendrix MJ
* Effects of a novel Nodal-targeting monoclonal antibody in melanoma (220 visite) (PDF 128 visite)
Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2015 Oct 27; 6(33): 34071-34086.
Impact Factor: 5.008
Dettagli    Esporta in BibTeX    Esporta in EndNote

Foca A, Sanguigno L, Foca G, Strizzi L, Iannitti R, Palumbo R, Hendrix MJ, Leonardi A, Ruvo M, Sandomenico A
* New Anti-Nodal Monoclonal Antibodies Targeting the Nodal Pre-Helix Loop Involved in Cripto-1 Binding (286 visite) (PDF 165 visite)
Int J Mol Sc (ISSN: 1422-0067electronic, 1422-0067linking, 1661-6596), 2015 Sep 7; 16(9): 21342-21362.
Impact Factor: 3.257
Dettagli    Esporta in BibTeX    Esporta in EndNote

Calce E, Monfregola L, Saviano M, De Luca S
* HER2-mediated anticancer drug delivery: strategies to prepare targeting ligands highly specific for the receptor (265 visite)
Curr Med Chem (ISSN: 1875-533xelectronic, 0929-8673linking), 2015 May 20; 22(21): 2525-2538.
Impact Factor: 3.455
Dettagli    Esporta in BibTeX    Esporta in EndNote

Monti SM, Supuran CT,  De Simone G
* DPP-4 inhibitors: a patent review (2012 - 2014) (108 visite)
Expert Opinion On Therapeutic Patents (ISSN: 1354-3776, 1744-7674electronic, 1354-3776linking), 2015 Feb; 25(2): 209-236.
Impact Factor: 4.626
Dettagli    Esporta in BibTeX    Esporta in EndNote

D'Ambrosio K, Carradori S, Monti SM, Buonanno M, Secci D, Vullo D, Supuran CT, De Simone G
* Out of the active site binding pocket for carbonic anhydrase inhibitors (157 visite) (PDF 134 visite)
Chem Commun (ISSN: 1359-7345, 1364-548x, 1364-548xelectronic), 2015 Jan 7; 51(2): 302-305.
Impact Factor: 6.567
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sorriento D, Del Giudice C, Bertamino A, Ciccarelli M, Gomez-Monterrey I, Campiglia P, Novellino E, Illario M, Trimarco B, De Luca N, Iaccarino G
* New small molecules, ISA27 and SM13, inhibit tumour growth inducing mitochondrial effects of p53 (117 visite)
Br J Cancer (ISSN: 0007-0920, 1532-1827electronic, 0007-0920print), 2015 Jan 6; 112(1): 77-85.
Impact Factor: 5.569
Dettagli    Esporta in BibTeX    Esporta in EndNote

Saccà F, Puorro G, Brunetti A, Capasso G, Cervo A, Cocozza S, De Leva M, Marsili A, Pane C, Quarantelli M, Russo CV, Trepiccione F, De Michele G, Filla A, Morra VB
* A randomized controlled pilot trial of lithium in spinocerebellar ataxia type two (127 visite)
J Neurol (ISSN: 0340-5354, 1432-1459, 1432-1459electronic), 2015 Jan; 262(1): 149-153.
Impact Factor: 3.408
Dettagli    Esporta in BibTeX    Esporta in EndNote

Klauzinska M, Bertolette D, Tippireddy S, Strizzi L, Gray PC, Gonzales M, Duroux M, Ruvo M, Wechselberger C, Castro NP, Rangel MC, Focà A, Sandomenico A, Hendrix MJC, Salomon D, Cuttitta F
* Cripto-1: an extracellular protein – connecting the sequestered biological dots (123 visite)
Connective Tissue Research (ISSN: 0300-8207), 2015; N/D: N/D-N/D.
Impact Factor: 1.411
Dettagli    Esporta in BibTeX    Esporta in EndNote

Yousif AM, Minopoli M, Bifulco K, Ingangi V, Di Carluccio G, Merlino F, Motti ML, Grieco P, Carriero MV
* Cyclization of the urokinase receptor-derived Ser-Arg-Ser-Arg-Tyr peptide generates a potent inhibitor of trans-endothelial migration of monocytes (143 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2015; 10(5): N/D-N/D.
Impact Factor: 3.057
Dettagli    Esporta in BibTeX    Esporta in EndNote

Merlo S, Basile L, Giuffrida ML, Sortino MA, Guccione S, Copani A
* Identification of 5-Methoxyflavone as a Novel DNA Polymerase-Beta Inhibitor and Neuroprotective Agent against Beta-Amyloid Toxicity (3 visite)
J Nat Prod (ISSN: 0163-3864), 2015; 78(11): 2704-2711.
Impact Factor:
Dettagli    Esporta in BibTeX    Esporta in EndNote

Mercurio FA, Di Natale C, Pirone L, Scognamiglio PL, Marasco D, Pedone EM, Saviano M, Leone M
* Peptide Fragments of Odin-Sam1: Conformational Analysis and Interaction Studies with EphA2-Sam (153 visite)
Chembiochem (ISSN: 1439-4227, 1439-7633, 1439-7633electronic), 2015; 16(11): 1629-1636.
Impact Factor: 2.85
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sandomenico A, Celentano V, D'Andrea LD, Palmieri G, Ruvo M
* Screening of beta-hairpin peptide-engrafted 1, 2, 3-triazoles to identify APEH enzyme inhibitors (104 visite)
Rsc Adv (ISSN: 2046-2069), 2015; 5(13): 9965-9972.
Impact Factor: 3.289
Dettagli    Esporta in BibTeX    Esporta in EndNote

Tornatore L, Sandomenico A, Raimondo D, Low C, Rocci A, Tralau-Stewart C, Capece D, D'Andrea D, Bua M, Boyle E, van Duin M, Zoppoli P, Jaxa-Chamiec A, Thotakura AK, Dyson J, Walker BA, Leonardi A, Chambery A, Driessen C, Sonneveld P, Morgan G, Palumbo A, Tramontano A, Rahemtulla A, Ruvo M, Franzoso G
* Cancer-selective targeting of the NF-kappaB survival pathway with GADD45beta/MKK7 inhibitors (225 visite)
Cancer Cell (ISSN: 1878-3686, 1535-6108), 2014 Oct 13; 26(4): 495-508.
Impact Factor: 23.523
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lanzillo R, Liuzzi R, Vallefuoco L, Moccia M, Amato L, Vacca G, Vacchiano V, Portella G, Brescia Morra V
* JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level (95 visite)
Ther Clin Risk Manag (ISSN: 1178-203x, 1176-6336linking), 2014 Oct 9; 10: 807-814.
Impact Factor: 1.469
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ringhieri P, Iannitti R, Nardon C, Palumbo R, Fregona D, Morelli G, Accardo A
* Target selective micelles for bombesin receptors incorporating Au(III)-dithiocarbamato complexes (140 visite)
Int J Pharm (ISSN: 0378-5173, 1873-3476), 2014 Oct 1; 473(1-2): 194-202.
Impact Factor: 3.65
Dettagli    Esporta in BibTeX    Esporta in EndNote

Capasso D, De Paola I, Liguoro A, Del Gatto A, Di Gaetano S, Guarnieri D, Saviano M, Zaccaro L
* Rgdechi-Hcit: Alpha V Beta 3 Selective Pro-Apoptotic Peptide As Potential Carrier For Drug Delivery Into Melanoma Metastatic Cells (130 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2014 Sep 23; 9(9): e106441-e106441.
Impact Factor: 3.234
Dettagli    Esporta in BibTeX    Esporta in EndNote

Iommelli F, De Rosa V, Gargiulo S, Panico M, Monti M, Greco A, Gramanzini M, Ortosecco G, Fonti R, Brunetti A, Del Vecchio S
* Monitoring Reversal of MET-Mediated Resistance to EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Using 3 '-Deoxy-3 '-[F-18]-Fluorothymidine Positron Emission Tomography (185 visite)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2014 Sep 15; 20(18): 4806-4815.
Impact Factor: 8.722
Dettagli    Esporta in BibTeX    Esporta in EndNote

Messori L, Cinellu MA, Merlino A
* Protein Recognition of Gold-Based Drugs: 3D Structure of the Complex Formed When Lysozyme Reacts with Aubipy(c) (124 visite)
Acs Med Chem Lett (ISSN: 1948-5875, 1948-5875print, 1948-5875linking), 2014 Jul 31; 5(10): 1110-1113.
Impact Factor: 3.12
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gallicchio R, Giacomobono S, Nardelli A, Pellegrino T, Simeon V, Gattozzi D, Maddalena F, Mainenti PP, Storto G
* Palliative Treatment Of Bone Metastases With Samarium-153 Edtmp At Onset Of Pain (126 visite)
Journal Of Bone And Mineral Metabolism (ISSN: 1435-5604, 0914-8779, 0914-8779linking), 2014 Jul; 32(4): 434-440.
Impact Factor: 2.46
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gallicchio R, Mansueto G, Simeon V, Nardelli A, Guariglia R, Capacchione D, Soscia E, Pedicini P, Gattozzi D, Musto P, Storto G
* F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma (112 visite)
European Journal Of Haematology (ISSN: 0902-4441, 0902-4441linking), 2014 May; 92(5): 382-389.
Impact Factor: 2.066
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cella L, Liuzzi R, D'Avino V, Conson M, Di Biase A, Picardi M, Pugliese N, Solla R, Salvatore M, Pacelli R
* Pulmonary damage in Hodgkin's lymphoma patients treated with sequential chemo-radiotherapy: Predictors of radiation-induced lung injury (121 visite)
Acta Oncol Acta Oncologica (ISSN: 0284-186x, 1651-226x), 2014 May; 53(5): 613-619.
Impact Factor: 2.997
Dettagli    Esporta in BibTeX    Esporta in EndNote

Accardo A, Aloj L, Aurilio M, Morelli G, Tesauro D
* Receptor binding peptides for target-selective delivery of nanoparticles encapsulated drugs (199 visite)
Int J Nanomed (ISSN: 1176-9114, 1178-2013, 1178-2013electronic), 2014 Mar 27; 9(1): 1537-1557.
Impact Factor: 4.383
Dettagli    Esporta in BibTeX    Esporta in EndNote

Petretta M, Cuocolo A
Letter by Petretta and Cuocolo regarding article, "Four-variable risk model in men and women with heart failure" (99 visite)
Circulation Heart Failure (ISSN: 1941-3297, 1941-3289), 2014 Mar 1; 7(2): 380-380.
Impact Factor: 5.867
Dettagli    Esporta in BibTeX    Esporta in EndNote

Rai M, Kon K, Ingle A, Duran N, Galdiero S, Galdiero M
* Broad-spectrum bioactivities of silver nanoparticles: the emerging trends and future prospects (355 visite)
Applied Microbiology And Biotechnology (ISSN: 0175-7598), 2014 Mar; 98(5): 1951-1961.
Impact Factor: 3.337
Dettagli    Esporta in BibTeX    Esporta in EndNote

D'Ambrosio K, Lopez M, Dathan NA, Ouahrani-bettache S, Köhler S, Ascione G, Monti SM, Winum JY, De Simone G
* Structural basis for the rational design of new anti-Brucella agents: The crystal structure of the C366S mutant of l-histidinol dehydrogenase from Brucella suis (149 visite)
Biochimie (ISSN: 0300-9084, 1638-6183, 1638-6183electronic), 2014 Feb; 97(1): 114-120.
Impact Factor: 2.963
Dettagli    Esporta in BibTeX    Esporta in EndNote

GrassoG, Magrì A, Bellia F, Pietropaolo A, La Mendola D, Rizzarelli E
* The Copper (ii) And Zinc (ii) Coordination Mode Of Hexxh And Hxxeh Motif In Small Peptides: The Role Of Carboxylate Location And Hydrogen Bonding Network (147 visite)
J Chem Res (ISSN: 1873-3344electronic, 0162-0134linking, 0162-0134print), 2014 Jan; 130(1): 92-102.
Impact Factor: 3.444
Dettagli    Esporta in BibTeX    Esporta in EndNote

Dathan NA, Alterio V, Troiano E, Vullo D, Ludwig M, De Simone G, Supuran CT, Monti SM
* Biochemical Characterization Of The Chloroplastic β-Carbonic Anhydrase From Flaveria Bidentis (l. ) "kuntze" (132 visite)
J Enzyme Inhib Med Chem (ISSN: 1475-6366, 1475-6374electronic, 1475-6366linking), 2014; 29(4): 500-504.
Impact Factor: 2.332
Dettagli    Esporta in BibTeX    Esporta in EndNote

Dynkevich Y, Rother KI, Whitford I, Qureshi S, Galiveeti S, Szulc AL, Danoff A, Breen TL, Kaviani N, Shanik MH, LeRoith D, Vigneri R, Koch CA, Roth J
* Tumors, IGF-2, and Hypoglycemia: Insights From the Clinic, the Laboratory, and the Historical Archive (690 visite)
Endocrine Reviews (ISSN: 0163-769x), 2013 Dec; 34(6): 798-826.
Impact Factor: 19.358
Dettagli    Esporta in BibTeX    Esporta in EndNote

Bergamo P, Cocca E, Palumbo R, Gogliettino M, Rossi M, Palmieri G
* RedOx status, proteasome and APEH: Insights into anticancer mechanisms of t10, c12-conjugated linoleic acid isomer on A375 melanoma cells (144 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2013 Nov 19; 8(11): N/D-N/D.
Impact Factor: 3.534
Dettagli    Esporta in BibTeX    Esporta in EndNote

Rami M, Dubois L, Parvathaneni NK, Alterio V, van Kuijk SJ, Monti SM, Lambin P, De Simone G, Supuran CT, Winum JY
* Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides/sulfamides/sulfamates (181 visite)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2013 Nov 14; 56(21): 8512-8520.
Impact Factor: 5.48
Dettagli    Esporta in BibTeX    Esporta in EndNote

Vergara A, Russo Krauss I, Montesarchio D, Paduano L, Merlino A
* Investigating the Ruthenium Metalation of Proteins: X-ray Structure and Raman Microspectroscopy of the Complex between RNase A and AziRu (97 visite)
Inorg Chem (ISSN: 0020-1669, 1520-510x, 1520-510xelectronic), 2013 Oct 7; 52(19): 10714-10716.
Impact Factor: 4.794
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pellerito O, Prinzivalli C, Foresti E, Sabatino P, Abbate M, Casella G, Fiore T, Scopelliti M, Pellerito C, Giuliano M, Grasso G, Pellerito L
* Synthesis, chemical characterization and biological activity of new histone acetylation/deacetylation specific inhibitors: A novel and potential approach to cancer therapy (147 visite)
J Chem Res (ISSN: 0162-0134, 1873-3344, 0162-0134print), 2013 Sep; 125: 16-25.
Impact Factor: 3.274
Dettagli    Esporta in BibTeX    Esporta in EndNote

Madonna S, Scarponi C, Doti N, Carbone T, Cavani A, Scognamiglio PL, Marasco D, Albanesi C
* Therapeutical potential of a peptide mimicking the SOCS1 kinase inhibitory region in skin immune responses (121 visite)
Eur J Immunol (ISSN: 0014-2980), 2013 Jul; 43(7): 1883-1895.
Impact Factor: 4.518
Dettagli    Esporta in BibTeX    Esporta in EndNote

Squeglia F, Romanò MF, Ruggiero A, Vitagliano L, De Simone A, Berisio R
* Carbohydrate recognition by RpfB from mycobacterium tuberculosis unveiled by crystallographic and molecular dynamics analyses (136 visite)
Biophysical Journal (ISSN: 0006-3495, 1542-0086), 2013 Jun 4; 104(11): 2530-2539.
Impact Factor: 3.832
Dettagli    Esporta in BibTeX    Esporta in EndNote

Monti SM, Supuran CT, De Simone G
* Anticancer carbonic anhydrase inhibitors: A patent review (2008-2013) (146 visite)
Expert Opinion On Therapeutic Patents (ISSN: 1354-3776, 1744-7674electronic), 2013 Jun; 23(6): 737-749.
Impact Factor: 3.441
Dettagli    Esporta in BibTeX    Esporta in EndNote

Storto G, Gallicchio R, Pellegrino T, Nardelli A,  De Luca S, Capacchione D, Sirignano C, Pace L
* Impact of F-18-fluoride PET-CT on implementing early treatment of painful bone metastases with Sm-153 EDTMP (111 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897, 0969-8051linking), 2013 May; 40(4): 518-523.
Impact Factor: 2.408
Dettagli    Esporta in BibTeX    Esporta in EndNote

Marotta V, Ramundo V, Camera L, Del Prete M, Fonti R, Esposito R, Palmieri G, Salvatore M, Vitale M, Colao A, Faggiano A
* Sorafenib in advanced iodine-refractory differentiated thyroid cancer: Efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET (195 visite)
Clin Endocrinol (ISSN: 0300-0664, 1365-2265, 1365-2265electronic), 2013 May; 78(5): 760-767.
Impact Factor: 3.353
Dettagli    Esporta in BibTeX    Esporta in EndNote

Vergara A, D’Errico G, Montesarchio D, Mangiapia G, Paduano L, Merlino A
* Interaction of Anticancer Ruthenium Compounds with Proteins: High-Resolution X-ray Structures and Raman Microscopy Studies of the Adduct between Hen Egg White Lysozyme and AziRu (116 visite)
Inorg Chem (ISSN: 0020-1669, 1520-510x, 1520-510xelectronic), 2013 Apr 15; 52(8): 4157-4159.
Impact Factor: 4.794
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lanzillo R, Bonavita S, Quarantelli M, Vacca G, Lus G, Amato L, Carotenuto A, Tedeschi G, Orefice G, Brescia Morra V
* Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice (77 visite)
Neurol Sci (ISSN: 1590-1874, 1590-0187, 1590-3478), 2013 Apr; 34(4): 521-528.
Impact Factor: 0.38
Dettagli    Esporta in BibTeX    Esporta in EndNote

Accardo A, Mangiapia G, Paduano L, Morelli G, Tesauro D
* Octreotide labeled aggregates containing platinum complexes as nanovectors for drug delivery (159 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2013 Apr; 19(4): 190-197.
Impact Factor: 1.862
Dettagli    Esporta in BibTeX    Esporta in EndNote

Monti SM, De Simone G, Dathan NA, Ludwig M, Vullo D, Scozzafava A, Capasso C, Supuran CT
* Kinetic And Anion Inhibition Studies Of A Beta-Carbonic Anhydrase (fbica 1) From The C-4 Plant Flaveria Bidentis (143 visite)
Bioorg Med Chem Lett (ISSN: 0960-894x), 2013 Mar 15; 23(6): 1626-1630.
Impact Factor: 2.331
Dettagli    Esporta in BibTeX    Esporta in EndNote

Calce E, Monfregola L, Sandomenico A, Saviano M, De Luca S
* Fluorescence study for selecting specific ligands toward HER2 receptor: An example of receptor fragment approach (120 visite)
Eur J Med Chem (ISSN: 0223-5234, 1768-3254, 1768-3254electronic), 2013 Mar; 61: 116-121.
Impact Factor: 3.432
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pisano M, De Paola I, Nieddu V, Sassu I, Cossu S, Galleri G, Del Gatto A, Budroni M, Cossu A, Saviano M, Palmieri G, Zaccaro L, Rozzo C
* In vitro activity of the alphavbeta3 integrin antagonist RGDechi-hCit on malignant melanoma cells (111 visite)
Anticancer Res (ISSN: 0250-7005, 0250-0700, 1791-7530electronic), 2013 Mar; 33(3): 871-879.
Impact Factor: 1.045
Dettagli    Esporta in BibTeX    Esporta in EndNote

D'Angelo D, Borbone E, Palmieri D, Uboldi S, Esposito F, Frapolli R, Pacelli R, D'Incalci M, Fusco A
* The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedin (121 visite)
European Journal Of Cancer (ISSN: 0959-8049), 2013 Mar; 49(5): 1142-1151.
Impact Factor: 4.819
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ruggiero A, Marchant J, Squeglia F, Makarov V, De Simone A, Berisio R
* Molecular determinants of inactivation of the resuscitation promoting factor B from Mycobacterium tuberculosis (101 visite)
J Biomol Struct Dyn (ISSN: 0739-1102, 1538-0254electronic), 2013 Feb 1; 31(2): 195-205.
Impact Factor: 2.983
Dettagli    Esporta in BibTeX    Esporta in EndNote

Rosa R, Marciano R, Malapelle U, Formisano L, Nappi L, D'Amato C, D'Amato V, Damiano V, Marf G, Del Vecchio S, Zannetti A, Greco A, De Stefano A, Carlomagno C, Veneziani BM, Troncone G, De Placido S, Bianco R
* Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models (145 visite)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2013 Jan 1; 19(1): 138-147.
Impact Factor: 8.193
Dettagli    Esporta in BibTeX    Esporta in EndNote

Buanne P, Renzone G, Monteleone F, Vitale M, Monti SM, Sandomenico A, Garbi C, Montanaro D, Accardo M, Troncone G, Zatovicova M, Csaderova L, Supuran CT, Pastorekova S, Scaloni A, De Simone G, Zambrano N
* Characterization of carbonic anhydrase ix interactome reveals proteins assisting its nuclear localization in hypoxic cells (123 visite)
J Proteome Res (ISSN: 1535-3893), 2013 Jan; 12(1): 282-292.
Impact Factor: 5.001
Dettagli    Esporta in BibTeX    Esporta in EndNote

Scalia M, Satriano C, Greca R, Stella AM, Rizzarelli E, Spina-Purrello V
* PARP-1 inhibitors DPQ and PJ-34 negatively modulate proinflammatory commitment of human glioblastoma cells (149 visite)
Neurochemical Research (ISSN: 1573-6903, 0364-3190), 2013 Jan; 38(1): 50-58.
Impact Factor: 2.551
Dettagli    Esporta in BibTeX    Esporta in EndNote

Tedesco I, Russo M, Bilotto S, Spagnuolo C, Scognamiglio A, Palumbo R, Nappo A, Iacomino G, Moio L, Russo GL
* Dealcoholated red wine induces autophagic and apoptotic cell death in an osteosarcoma cell line (133 visite)
Food Chem Toxicol (ISSN: 0278-6915), 2013; 60: 377-384.
Impact Factor: 2.61
Dettagli    Esporta in BibTeX    Esporta in EndNote

Costa B, Bendinelli S, Gabelloni P, Da Pozzo E,  Daniele S, Scatena F, Vanacore R, Campiglia P, Bertamino A, Gomez-Monterrey I, Sorriento D, Del Giudice C, Iaccarino G, Novellino E, Martini C
* Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor (108 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2013; 8(8): e72281-e72281.
Impact Factor: 3.534
Dettagli    Esporta in BibTeX    Esporta in EndNote

Messori L, Scaletti F, Massai L, Cinellu MA, Gabbiani C, Vergara A, Merlino A
* The mode of action of anticancer gold-based drugs: a structural perspective (108 visite)
Chem Commun (ISSN: 1359-7345, 1364-548x, 1364-548xelectronic), 2013; 49(86): 10100-10102.
Impact Factor: 6.718
Dettagli    Esporta in BibTeX    Esporta in EndNote

Berisio R
* Learning from pathogens: Exploiting host-pathogen liaison for therapeutic development (127 visite)
Curr Protein Pept Sci (ISSN: 1389-2037), 2012 Dec; 13(8): 697-698.
Impact Factor: 2.326
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lanzillo R, Quarantelli M, Bonavita S, Ventrella G, Lus G, Vacca G, Prinster A, Orefice G, Tedeschi G, Brescia Morra V
* Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: A head-to-head retrospective study (115 visite)
Acta Neurol Scand (ISSN: 0001-6314, 1600-0404), 2012 Nov; 126(5): 306-314.
Impact Factor: 2.474
Dettagli    Esporta in BibTeX    Esporta in EndNote

Berisio R
* Editorial: cell processes in bacterial diseases (133 visite)
Protein Pept Lett (ISSN: 0929-8665, 1875-5305), 2012 Oct; 19(10): 1011-1012.
Impact Factor: 1.994
Dettagli    Esporta in BibTeX    Esporta in EndNote

Kaprelyants AS, Mukamolova GV, Ruggiero A, Makarov VA, Demina GR, Shleeva MO, Potapov VD, Shramko PA
* Resuscitation-promoting Factors (Rpf): In Search of Inhibitors (125 visite)
Protein Pept Lett (ISSN: 0929-8665, 1875-5305), 2012 Oct; 19(10): 1026-1034.
Impact Factor: 1.994
Dettagli    Esporta in BibTeX    Esporta in EndNote

Tagliamonte M, Marasco D, Ruggiero A, de Stradis A, Tornesello ML, Totrov M, Buonaguro FM, Buonaguro L
* HIV p24 as Scaffold for Presenting Conformational HIV Env Antigens (147 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2012 Sep 17; 7(8): N/D-N/D.
Impact Factor: 3.73
Dettagli    Esporta in BibTeX    Esporta in EndNote

Risitano AM, Imbriaco M, Marando L, Seneca E, Soscia E, Malcovati L, Iori AP, Pane F, Notaro R, Matarazzo M
* From perpetual haemosiderinuria to possible iron overload: iron redistribution in paroxysmal nocturnal haemoglobinuria patients on eculizumab by magnetic resonance imaging (106 visite)
Br J Haematol (ISSN: 0007-1048, 0007-1048linking, 1365-2141electronic), 2012 Sep; 158(3): 415-418.
Impact Factor: 4.942
Dettagli    Esporta in BibTeX    Esporta in EndNote

Caraci F, Battaglia G, Sortino MA, Spampinato S, Molinaro G, Copani A, Nicoletti F, Bruno V
* Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic? (153 visite)
Neurochem Int (ISSN: 0197-0186), 2012 Sep; 61(4): 559-565.
Impact Factor: 2.659
Dettagli    Esporta in BibTeX    Esporta in EndNote

Santoro AM, Lo Giudice MC, D'Urso A, Lauceri R, Purrello R, Milardi D
* Cationic porphyrins are reversible proteasome inhibitors (154 visite)
J Am Chem Soc (ISSN: 0002-7863, 0002-2786, 1520-5126), 2012 Jun 27; 134(25): 10451-10457.
Impact Factor: 10.677
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pedicini P, Caivano R, Jereczek-Fossa BA, Strigari L, Vischioni B, Alterio D, Cremonesi M, Botta F, Nappi A, Improta G, Storto G, Benassi M, Orecchia R
* Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors (106 visite)
Theor Biol Med Model (ISSN: 1742-4682), 2012 Jun 19; 9(1): 23-23.
Impact Factor: 1.461
Dettagli    Esporta in BibTeX    Esporta in EndNote

De Simone G, Supuran CT
* (In)organic anions as carbonic anhydrase inhibitors (134 visite)
J Chem Res (ISSN: 0162-0134, 1873-3344, 0162-0134print), 2012 Jun; 111: 117-129.
Impact Factor: 3.197
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sciacca MF, Chillemi R, Sciuto S, Pappalardo M, La Rosa C, Grasso D, Milardi D
* Interactions of two O-phosphorylresveratrol derivatives with model membranes (86 visite)
Arch Biochem Biophys (ISSN: 1096-0384, 0003-3986), 2012 May; 521(1-2): 111-116.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sandomenico A, Russo A, Palmieri G, Bergamo P, Gogliettino M, Falcigno L, Ruvo M
* Small peptide inhibitors of acetyl-peptide hydrolase having an uncommon mechanism of inhibition and a stable bent conformation (135 visite)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2012 Mar 8; 55(5): 2102-2111.
Impact Factor: 5.614
Dettagli    Esporta in BibTeX    Esporta in EndNote

Zannetti A, Iommelli F, Speranza A, Salvatore M, Del Vecchio S
* 3'-deoxy-3'-18F-fluorothymidine (FLT) PET/CT to guide therapy with epidermal growth factor receptor (EGFR) antagonists and Bcl-xL inhibitors in non-small cell lung cancer (237 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2012 Mar 1; 53(3): 443-450.
Impact Factor: 5.774
Dettagli    Esporta in BibTeX    Esporta in EndNote

Zannetti A, Iommelli F, Speranza A, Salvatore M, Del Vecchio S
* 3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer (175 visite)
J Nucl Med (ISSN: 1535-5667, 0161-5505, 1535-5667electronic), 2012 Mar 1; 53(3): 443-450.
Impact Factor: 5.774
Dettagli    Esporta in BibTeX    Esporta in EndNote

Monti SM, Supuran CT, De Simone G
* Carbonic anhydrase IX as a target for designing novel anticancer drugs (185 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2012 Feb; 19(6): 821-830.
Impact Factor: 4.07
Dettagli    Esporta in BibTeX    Esporta in EndNote

De Simone G
* Editorial: Zinc Metallo-Enzymes As Target For Drug Design (116 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2012 Feb; 19(6): 820-1012.
Impact Factor: 4.07
Dettagli    Esporta in BibTeX    Esporta in EndNote

Caraci F, Spampinato S, Sortino MA, Bosco P, Battaglia G, Bruno V, Drago F, Nicoletti F, Copani A
* Dysfunction of TGF-β1 signaling in Alzheimer's disease: Perspectives for neuroprotection (234 visite)
Cell Tissue Res (ISSN: 0302-766x), 2012 Jan; 347(1): 291-301.
Impact Factor: 3.677
Dettagli    Esporta in BibTeX    Esporta in EndNote

Galdiero S, Vitiello M, Finamore E, Mansi R, Galdiero M, Morelli G, Tesauro D
* Activation of monocytic cells by immunostimulatory lipids conjugated to peptide antigens (128 visite)
Molecular Biosystems (ISSN: 1742-206x), 2012; 8(12): 3166-3177.
Impact Factor: 3.35
Dettagli    Esporta in BibTeX    Esporta in EndNote

Folgiero V, Di Carlo SE, Bossi G, Spugnini E, Di Benedetto A, Bon G, Milella M, Fabi A, Accardo A, Morelli G, Mottolese M, Falcioni R
* Inhibition of p85, the non-catalytic subunit of phosphatidylinositol 3-kinase, exerts potent antitumor activity in human breast cancer cells (131 visite)
Cell Death & (ISSN: 2041-4889, 2041-4889electronic), 2012; 3(12): N/D-N/D.
Impact Factor: 6.044
Dettagli    Esporta in BibTeX    Esporta in EndNote

Castellano I, Merlino A
* γ-glutamyltranspeptidases: Sequence, structure, biochemical properties, and biotechnological applications (108 visite)
Cell Mol Life Sci (ISSN: 1420-682x), 2012; 69(20): 3381-3394.
Impact Factor: 5.615
Dettagli    Esporta in BibTeX    Esporta in EndNote

Accardo A, Salsano G, Morisco A, Aurilio M, Parisi A, Maione F, Cicala C, Tesauro D, Aloj L, De Rosa G, Morelli G
* Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: A potential theranostic agent (146 visite)
Int J Nanomed (ISSN: 1176-9114, 1178-2013, 1178-2013electronic), 2012; 7: 2007-2017.
Impact Factor: 3.463
Dettagli    Esporta in BibTeX    Esporta in EndNote

D'Errico G, Ercole C, Lista M, Pizzo E, Falanga A, Galdiero S, Spadaccini R, Picone D
* Enforcing the positive charge of N-termini enhances membrane interaction and antitumor activity of bovine seminal ribonuclease (105 visite)
Biochim Biophys Acta (ISSN: 0005-2736, 0006-3002, 0925-4439), 2011 Dec; 1808(12): 3007-3015.
Impact Factor: 3.99
Dettagli    Esporta in BibTeX    Esporta in EndNote

Tarallo R, Accardo A, Falanga A, Guarnieri D, Vitiello G, Netti P, D'Errico G, Morelli G, Galdiero S
* Clickable functionalization of liposomes with the gH625 peptide from herpes simplex virus type i for intracellular drug delivery (117 visite)
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2011 Nov 4; 17(45): 12659-12668.
Impact Factor: 5.925
Dettagli    Esporta in BibTeX    Esporta in EndNote

Adinolfi M, Capasso D, Di Gaetano S, Iadonisi A, Leone L, Pastore A
* A straightforward synthetic access to symmetrical glycosyl disulfides and biological evaluation thereof (110 visite)
Org Biomol Chem (ISSN: 1477-0520, 1477-0539, 1477-0539electronic), 2011 Sep 21; 9(18): 6278-6283.
Impact Factor: 3.696
Dettagli    Esporta in BibTeX    Esporta in EndNote

Calabrese V, Cornelius C, Cuzzocrea S, Iavicoli I, Rizzarelli E, Calabrese EJ
* Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity (209 visite)
Molecular Aspects Of Medicine (ISSN: 1872-9452, 0098-2997), 2011 Sep; 32(4-6): 279-304.
Impact Factor: 9.97
Dettagli    Esporta in BibTeX    Esporta in EndNote

Janda E, Palmieri C, Pisano A, Pontoriero M, Iaccino E, Falcone C, Fiume G, Gaspari M, Nevolo M, Di Salle E, Rossi A, De Laurentiis A, Greco A, Di Napoli D, Verheij E, Britti D, Lavecchia L, Quinto I, Scala G
* Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtkγ (106 visite)
Blood (ISSN: 0006-4971, 0006-6497, 0390-6078), 2011 Jun 16; 117(24): 6520-6531.
Impact Factor: 9.898
Dettagli    Esporta in BibTeX    Esporta in EndNote

Milite C, Castellano S, Benedetti R, Tosco A, Ciliberti C, Vicidomini C, Boully L, Franci G, Altucci L, Mai A, Sbardella G
* Modulation of the activity of histone acetyltransferases by long chain alkylidenemalonates (LoCAMs) (107 visite)
Bioorg Med Chem (ISSN: 0968-0896, 1464-3391, 1464-3391electronic), 2011 Jun 15; 19(12): 3690-3701.
Impact Factor: 2.921
Dettagli    Esporta in BibTeX    Esporta in EndNote

Perrone-filardi P, Dellegrottaglie S, Rudd JH, Costanzo P, Marciano C, Vassallo E, Marsico F, Ruggiero D, Petretta MP, Chiariello M, Cuocolo A
* Molecular imaging of atherosclerosis in translational medicine (183 visite)
Eur J Nucl Med (ISSN: 1619-7089, 1619-7070, 0340-6997), 2011 May; 38(5): 969-975.
Impact Factor: 4.991
Dettagli    Esporta in BibTeX    Esporta in EndNote

Falciani C, Accardo A, Brunetti J, Tesauro D, Lelli B, Pini A, Bracci L, Morelli G
* Target-Selective Drug Delivery through Liposomes Labeled with Oligobranched Neurotensin Peptides (174 visite)
Chemmedchem (ISSN: 1860-7179, 1860-7187, 1860-7187electronic), 2011 Apr 4; 6(4): 678-685.
Impact Factor: 3.151
Dettagli    Esporta in BibTeX    Esporta in EndNote

Troise F, Monti M, Merlino A, Cozzolino F, Fedele C, Russo Krauss I, Sica F, Pucci P, D'Alessio G, De Lorenzo C
* A novel ErbB2 epitope targeted by human antitumor immunoagents (122 visite)
Febs Journal (ISSN: 1742-464x), 2011 Apr; 278(7): 1156-1166.
Impact Factor: 3.79
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lanzillo R, Orefice G, Prinster A, Ventrella G, Liuzzi R, Scarano V, Florio C, Vacca G, Brunetti A, Alfano B, Brescia Morra V, Bonavita V
* Predictive factors of neutralizing antibodies development in relapsing-remitting multiple sclerosis patients on interferon Beta-1b therapy (93 visite) (PDF 114 visite)
Neurol Sci (ISSN: 1590-1874, 1590-3478), 2011 Apr; 32(2): 287-292.
Impact Factor: 1.315
Dettagli    Esporta in BibTeX    Esporta in EndNote

Caraci F, Molinaro G, Battaglia G, Giuffrida ML, Riozzi B, Traficante A, Bruno V, Cannella M, Merlo S, Wang X, Heinz BA, Nisenbaum ES, Britton TC, Drago F, Sortino MA, Copani A, Nicoletti F
* Targeting group II Metabotropic Glutamate (mGlu) receptors for the treatment of psychosis associated with alzheimer's disease: Selective activation of mGlu2 receptors amplifies β-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective (267 visite)
Mol Pharmacol (ISSN: 0026-895x), 2011 Mar; 79(3): 618-626.
Impact Factor: 4.883
Dettagli    Esporta in BibTeX    Esporta in EndNote

Varnäs K, Nyberg S, Halldin C, Varrone A, Takano A, Karlsson P, Andersson J, McCarthy D, Smith M, Pierson ME, Söderström J, Farde L
* Quantitative analysis of [11C]AZ10419369 binding to 5-HT 1B receptors in human brain (155 visite)
J Cereb Blood Flow Metab (ISSN: 0271-678x), 2011 Jan; 31(1): 113-123.
Impact Factor: 5.008
Dettagli    Esporta in BibTeX    Esporta in EndNote

Avila FF, Improta R, Santoro F, Barone V
* Computing the inhomogeneous broadening of electronic transitions in solution: A first-principle quantum mechanical approach (92 visite)
Phys Chem Chem Phys (ISSN: 1463-9076, 1463-3907, 1463-9084electronic), 2011; 13(38): 17007-17012.
Impact Factor: 3.573
Dettagli    Esporta in BibTeX    Esporta in EndNote

Strianese D, Tranfa F, Finelli M, De Renzo A, Staibano S, Schiemer R, Cardone D, Pacelli R, Perna F, Mascolo M, De Rosa G, Bonavolonta G
* Hepatitis C virus infection in ocular adnexal lymphomas (80 visite)
Arch Ophthalmol (ISSN: 1538-3601, 0003-9950), 2010 Oct; 128(10): 1295-1299.
Impact Factor: 3.516
Dettagli    Esporta in BibTeX    Esporta in EndNote

Langella E, Pierre S, Ghattas W, Giorgi M, Réglier M, Saviano M, Esposito L, Hardré R
* Probing The Peptidylglycine Alpha-Hydroxylating Monooxygenase Active Site With Novel 4-Phenyl-3-Butenoic Acid Based Inhibitors (148 visite)
Chemmedchem (ISSN: 1860-7179, 1860-7187, 1860-7187electronic), 2010 Sep 3; 5(9): 1568-1576.
Impact Factor: 3.306
Dettagli    Esporta in BibTeX    Esporta in EndNote

Palmieri C, Falcone C, Iaccino E, Tuccillo FM, Gaspari M, Trimboli F, De Laurentiis A, Luberto L, Pontoriero M, Pisano A, Vecchio E, Fierro O, Panico M, Larobina M, Gargiulo S, Costa N, Dal Piaz F, Schiavone M, Arra C, Giudice A,  Palma G, Barbieri A, Quinto I, Scala G
* In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder (152 visite)
Blood (ISSN: 0006-4971, 0006-6497, 0390-6078), 2010 Jul 15; 116(2): 226-238.
Impact Factor: 10.558
Dettagli    Esporta in BibTeX    Esporta in EndNote

Di Lorenzo G, Imbimbo M, Leopardo D, Marciano R, Federico P, Buonerba C, Salvatore B, Marinelli A, Palmieri G. A
* A long-lasting response to sorafenib treatment in an advanced hepatocellular carcinoma patient (91 visite)
Int J Immunopathol Pharmacol (ISSN: 0394-6320), 2010 Jul; 23(3): 951-954.
Impact Factor: 2.685
Dettagli    Esporta in BibTeX    Esporta in EndNote

Kelly SE, Di Benedetto A, Greco A, Howard CM, Sollars VE, Primerano DA, Valluri JV, Claudio PP
* Rapid Selection and Proliferation of CD133(+) Cells from Cancer Cell Lines: Chemotherapeutic Implications (142 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2010 Apr 8; 5(4): N/D-N/D.
Impact Factor: 4.411
Dettagli    Esporta in BibTeX    Esporta in EndNote

Napolitano M, Ottaiano A, Mauro F, Ieranò C, Satriano R, Pacelli R, Franco R, De Angelis V, Castello G, Scala S
* CD4(+)CD45RA(+)CXCR4(+) lymphocytes are inversely associated with progression in stages I-III melanoma patients (87 visite)
Cancer Immunol Immunother (ISSN: 0340-7004, 0340-7004linking), 2010 Apr; 59(4): 511-517.
Impact Factor: 4.293
Dettagli    Esporta in BibTeX    Esporta in EndNote

Chambery A, Severino V, Di Maro A, D'Aniello A, Ruvo M, Parente A
* Quantification of thyrotropin-releasing hormone by liquid chromatography-electrospray mass spectrometry (124 visite)
Amino Acids (ISSN: 0939-4451, 1438-2199, 1438-2199electronic), 2010 Apr; 38(4): 1031-1041.
Impact Factor: 4.106
Dettagli    Esporta in BibTeX    Esporta in EndNote

Alberobello AT, D'Esposito V, Marasco D, Doti N, Ruvo M, Bianco R, Tortora G, Esposito I, Fiory F, Miele C, Beguinot F, Formisano P
* Selective Disruption of Insulin-like Growth Factor-1 (IGF-1) Signaling via Phosphoinositide-dependent Kinase-1 Prevents the Protective Effect of IGF-1 on Human Cancer Cell Death (108 visite)
J Biol Chem Journal Of Biological Chemistry (ISSN: 0021-9258, 1083-351x), 2010 Feb 26; 285(9): 6563-6572.
Impact Factor: 5.328
Dettagli    Esporta in BibTeX    Esporta in EndNote

De Simone G, Supuran CT
* Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target (161 visite)
Biochim Biophys Acta (ISSN: 1570-9639, 0006-3002, 0925-4439), 2010 Feb; 1804(2): 404-409.
Impact Factor: 2.773
Dettagli    Esporta in BibTeX    Esporta in EndNote

Storto G, De Renzo A, Pellegrino T, Perna F, De Falco T, Erra P, Nardelli A, Speranza A, Klain M, Rotoli B, Pace L
* Assessment of Metabolic Response to Radioimmunotherapy with (90)Y-Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (112 visite)
Radiology (ISSN: 0033-8419, 1527-1315, 0033-8419linking), 2010 Jan; 254(1): 245-252.
Impact Factor: 6.069
Dettagli    Esporta in BibTeX    Esporta in EndNote

Guler OO, De Simone G, Supuran CT
* Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII (201 visite)
Curr Med Chem (ISSN: 0929-8673, 1875-533x, 1875-533xelectronic), 2010; 17(15): 1516-1526.
Impact Factor: 4.63
Dettagli    Esporta in BibTeX    Esporta in EndNote

Supuran CT, Di Fiore A, Alterio V, Monti SM, De Simone G
* Recent advances in structural studies of the carbonic anhydrase family: The crystal structure of human CA IX and CA XIII (120 visite)
Curr Pharm Des Current Pharmaceutical Design (ISSN: 1381-6128, 1873-4286), 2010; 16(29): 3246-3254.
Impact Factor: 4.774
Dettagli    Esporta in BibTeX    Esporta in EndNote

Merlino A, Russo Krauss I, Perillo M, Mattia CA, Ercole C, Picone D, Vergara A, Sica F
* Toward an Antitumor Form of Bovine Pancreatic Ribonuclease: The Crystal Structure of Three Noncovalent Dimeric Mutants (104 visite)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2009 Dec; 91(12): 1029-1037.
Impact Factor: 2.605
Dettagli    Esporta in BibTeX    Esporta in EndNote

Giurato P, Candura A, Grasso G, Spoto G
* In situ identification of organic components of ink used in books from the 1900s by atmospheric pressure matrix assisted laser desorption ionization mass spectrometry (149 visite)
Appl Phys A (ISSN: 0947-8396), 2009 Nov; 97(2): 263-269.
Impact Factor: 1.595
Dettagli    Esporta in BibTeX    Esporta in EndNote

Giuffrida ML, Caraci F, Pignataro B, Cataldo S, De Bona P, Bruno V, Molinaro G, Pappalardo G, Messina A, Palmigiano A, Garozzo D, Nicoletti F, Rizzarelli E, Copani A
* Beta-Amyloid Monomers Are Neuroprotective (169 visite)
J Neurosci (ISSN: 1529-2401, 0270-6474), 2009 Sep 26; 29(34): 10582-10587.
Impact Factor: 3.669
Dettagli    Esporta in BibTeX    Esporta in EndNote

Alterio V, Hilvo M, Di Fiore A, Supuran CT, Pan P, Parkkila S, Scaloni A, Pastorek J, Pastorekova S, Pedone C, Scozzafava A, Monti SM, De Simone G
* Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX (203 visite)
Proc Natl Acad Sci U S A (ISSN: 0027-8424, 1091-6490, 0027-8424print), 2009 Sep 22; 106(38): 16233-16238.
Impact Factor: 9.432
Dettagli    Esporta in BibTeX    Esporta in EndNote

Carriero MV, Longanesi-cattani I, Bifulco K, Maglio O, Lista L, Barbieri A, Votta G, Masucci MT, Arra C, Franco R, De Rosa M, Stoppelli MP, Pavone V
* Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis (136 visite)
Mol Cancer Ther Molecular Cancer Therapeutics (ISSN: 1535-7163, 1538-8514electronic, 1535-7163linking), 2009 Sep; 8(9): 2708-2717.
Impact Factor: 4.953
Dettagli    Esporta in BibTeX    Esporta in EndNote

De Simone G, Scozzafava A, Supuran CT
* Which Carbonic Anhydrases are Targeted by the Antiepileptic Sulfonamides and Sulfamates? (113 visite)
Chem Biol Drug Des Chemical Biology And Drug Design (ISSN: 1747-0277, 1747-0285), 2009 Sep; 74(3): 317-321.
Impact Factor: 2.473
Dettagli    Esporta in BibTeX    Esporta in EndNote

Mancini M, Greco A, Speranza A, Salvatore M
* Ultrasound molecular imaging by targeted microbubble contrast agents (150 visite)
Minerva Biotecnol (ISSN: 1120-4826), 2009 Jun; 21(2): 97-110.
Impact Factor: 0.268
Dettagli    Esporta in BibTeX    Esporta in EndNote

La Mendola D, Magrì A, Hansson O, Bonomo RP, Rizzarelli E
* Copper(II) complexes with peptide fragments encompassing the sequence 122-130 of human doppel protein (106 visite)
Journal Of Inorganic Biochemistry, 2009 May; 103(5): 758-765.
Impact Factor: 3.444
Dettagli    Esporta in BibTeX    Esporta in EndNote

Peca C, Pacelli R, Elefante A, Del Basso De Caro ML, Vergara P, Mariniello G, Giamundo A, Maiuri F
* Early clinical and neuroradiological worsening after radiotherapy and concomitant temozolomide in patients with glioblastoma: Tumour progression or radionecrosis? (118 visite)
Clin Neurol Neurosurg (ISSN: 0303-8467), 2009 May; 111(4): 331-334.
Impact Factor: 1.303
Dettagli    Esporta in BibTeX    Esporta in EndNote

Di Fiore A, Monti SM, Hilvo M, Parkkila S, Romano V, Scaloni A, Pedone C, Scozzafava A, Supuran CT, De Simone G
* Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide (105 visite)
Proteins (ISSN: 1097-0134, 0887-3585, 1097-0134electronic), 2009 Jan; 74(1): 164-175.
Impact Factor: 3.085
Dettagli    Esporta in BibTeX    Esporta in EndNote

Merlino A, Avella G, Di Gaetano S, Arciello A, Piccoli R, Mazzarella L, Sica F
* Structural features for the mechanism of antitumor action of a dimeric human pancreatic ribonuclease variant (92 visite)
Protein Sci (ISSN: 0961-8368, 1469-896xelectronic, 0961-8368linking), 2009 Jan; 18(1): 50-57.
Impact Factor: 2.937
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sorriento D, Campanile A, Santulli G, Leggiero E, Pastore L, Trimarco B, Iaccarino G
* A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFκB activity (110 visite)
Mol Cancermolecular Cancer (ISSN: 1476-4598), 2009; 8: N/D-N/D.
Impact Factor: 4.16
Dettagli    Esporta in BibTeX    Esporta in EndNote

Chiechio S, Zammataro M, Morales ME, Busceti CL, Drago F, Th Gereau RW, Copani A, Nicoletti F
* Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain (109 visite)
Mol Pharmacol (ISSN: 0026-895x), 2009; 75(5): 1014-1020.
Impact Factor: 4.531
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sciacca MFM, Pappalardo M, Milardi D, Grasso DM, La Rosa C
* Calcium-Activated Membrane Interaction Of The Islet Amyloid Polypeptide: Implications In The Pathogenesis Of Type Ii Diabetes Mellitus (126 visite)
Arch Biochem Biophys, 2008 Sep 15; 65(1-2): 291-298.
Impact Factor: 3.043
Dettagli    Esporta in BibTeX    Esporta in EndNote

Woo LWL, Fischer DS, Sharland CM, Trusselle M, Foster PA, Chander SK, Di Fiore A, Supuran CT, De Simone G, Purohit A, Reed MJ, Potter BVL
* Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography (124 visite)
Mol Cancer Ther Molecular Cancer Therapeutics (ISSN: 1535-7163, 1538-8514electronic), 2008 Sep; 7(8): 2435-2444.
Impact Factor: 5.003
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sbardella G, Castellano S, Vicidomini C, Rotili D, Nebbioso A, Miceli M, Altucci L, Mai A
* Identification of long chain alkylidenemalonates as novel small molecule modulators of histone acetyltransferases (87 visite)
Bioorganic & Medicinal Chemistry Letters (ISSN: 0960-894x), 2008 May 1; 18(9): 2788-2792.
Impact Factor: 2.531
Dettagli    Esporta in BibTeX    Esporta in EndNote

Rendina D, De Filippo G, Viceconti R, Soscia E, Sirignano C, Salvatore M, Della Monica M, Scarano G, Mossetti G
* Interleukin (il)-6 And Receptor Activator Of Nuclear Factor (nf)-Kappab Ligand (rankl) Are Increased In The Serum Of A Patient With Primary Pachydermoperiostosis (116 visite)
Scand J Rheumatol (ISSN: 0300-9742), 2008 May; 37(3): 225-229.
Impact Factor: 2.345
Dettagli    Esporta in BibTeX    Esporta in EndNote

Leese MP, Jourdan FL, Gaukroger K, Mahon MF, Newman SP, Foster PA, Stengel C, Regis-Lydi S, Ferrandis E, Di Fiore A, De Simone G, Supuran CT, Purohit A, Reed MJ, Potter BVL
* Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents (130 visite)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2008 Mar 13; 51(5): 1295-1308.
Impact Factor: 4.898
Dettagli    Esporta in BibTeX    Esporta in EndNote

Scarpa R, Cuocolo A, Peluso R, Atteno M, Gisonni P, Iervolino S, Di Minno MND, Nicolai E, Salvatore M, Del Puente A
* Early psoriatic arthritis: the clinical spectrum (95 visite)
The Journal Of Rheumatology (ISSN: 0315-162x), 2008 Jan; 35(1): 137-141.
Impact Factor: 3.282
Dettagli    Esporta in BibTeX    Esporta in EndNote

Supuran CT, De Simone G
Carbonic anhydrases--an overview (114 visite)
Curr Pharm Des, 2008; 14(7): 603-614.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Improta R, Scalmani G, Frisch MJ, Barone V
* Toward effective and reliable fluorescence energies in solution by a new state specific polarizable continuum model time dependent density functional theory approach (90 visite)
J Chem Phys (ISSN: 0021-9606, 0897-690online), 2007 Sep 21; 127(7): N/D-N/D.
Impact Factor: 3.044
Dettagli    Esporta in BibTeX    Esporta in EndNote

Picardi M, De Renzo A, Pane F, Nicolai E, Pacelli R, Salvatore M, Rotoli B
* Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans (132 visite)
Leuk Lymphoma (ISSN: 1042-8194, 1026-8022linking), 2007 Sep; 48(9): 1721-1727.
Impact Factor: 1.512
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Zannetti A, Fonti R, Pace L, Salvatore M
* Nuclear imaging in cancer theranostics (194 visite)
Q J Nucl Med Mol Imaging (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2007 Jun; 51(2): 152-163.
Impact Factor: 1.724
Dettagli    Esporta in BibTeX    Esporta in EndNote

Catalano L, Del Vecchio S, Petruzziello F, Fonti R, Salvatore B, Martorelli C, Califano C, Caparrotti G, Segreto S, Pace L, Rotoli B
* Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis (138 visite)
Ann Hematol (ISSN: 0939-5555, 0939-5555linking), 2007 Jun; 86(6): 415-423.
Impact Factor: 2.342
Dettagli    Esporta in BibTeX    Esporta in EndNote

Santoro F, Lami A, Improta R, Barone V
* Effective method to compute vibrationally resolved optical spectra of large molecules at finite temperature in the gas phase and in solution (88 visite)
J Chem Phys (ISSN: 0021-9606, 0897-690online), 2007 May 14; 126(18): 184102-184102.
Impact Factor: 3.044
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ragno R, Simeoni S, Castellano S, Vicidomini C, Mai A, Caroli A, Tramontano A, Bonaccini C, Trojer P, Bauer I, Brosch G, Sbardella G
* Small molecule inhibitors of histone arginine methyltransferases: Homology modeling, molecular docking, binding mode analysis, and biological evaluations (151 visite)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2007 Mar 22; 50(6): 1241-1253.
Impact Factor: 4.895
Dettagli    Esporta in BibTeX    Esporta in EndNote

Di Fiore A, Scozzafava A, Winum JY, Montero JL, Pedone C, Supuran CT, De Simone G
* Carbonic anhydrase inhibitors: binding of an antiglaucoma glycosyl-sulfanilamide derivative to human isoform II and its consequences for the drug design of enzyme inhibitors incorporating sugar moieties (126 visite)
Bioorg Med Chem Lett Bioorganic And Medicinal Chemistry Letters (ISSN: 0960-894x), 2007 Mar 15; 17(6): 1726-1731.
Impact Factor: 2.604
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cuocolo A, Milcinski M, Bischof Delaloye A
* Syllabus for postgraduate specialisation in Nuclear Medicine: 2006/07 update (137 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2007 Mar; 34(3): 433-436.
Impact Factor: 4.101
Dettagli    Esporta in BibTeX    Esporta in EndNote

Messere A, Fabbri E, Borgatti M, Gambari R, Di Blasio B, Pedone C, Romanelli A
* Antiproliferative activity of Pt(II) and Pd(II) phosphine complexes with thymine and thymidine (89 visite)
J Chem Res (ISSN: 0162-0134, 1873-3344, 0162-0134print), 2007 Feb; 101(2): 254-260.
Impact Factor: 3.663
Dettagli    Esporta in BibTeX    Esporta in EndNote

Minopoli G, Stante M, Napolitano F, Telese F, Aloia L, De Felice M, Di Lauro R, Pacelli R, Brunetti A, Zambrano N, Russo T
* Essential roles for Fe65, Alzheimer amyloid precursor-binding protein, in the cellular response to DNA damage (111 visite)
J Biol Chem Journal Of Biological Chemistry (ISSN: 0021-9258, 1083-351x), 2007 Jan 12; 282(2): 831-835.
Impact Factor: 5.581
Dettagli    Esporta in BibTeX    Esporta in EndNote

Palmieri G, Marino M, Salvatore M, Budillon A, Meo G, Caraglia M, Montella L
* Cetuximab is an active treatment of metastatic and chemorefractory thymoma (92 visite)
Frontiers In Bioscience (ISSN: 1093-9946, 1093-4715), 2007 Jan 1; 12(2): 757-761.
Impact Factor: 2.989
Dettagli    Esporta in BibTeX    Esporta in EndNote

Improta R, Barone V, Santoro F
* Ab initio calculations of absorption spectra of large molecules in solution: Coumarin C153 (96 visite)
Angew Chem Int Ed (ISSN: 1433-7851, 1521-3773electronic), 2007; 46(3): 405-408.
Impact Factor: 10.031
Dettagli    Esporta in BibTeX    Esporta in EndNote

Accardo A, Tesauro D, Mangiapia G, Pedone C, Morelli G
* Nanostructures by self-assembling peptide amphiphile as potential selective drug carriers (137 visite)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2007; 88(2): 115-121.
Impact Factor: 2.389
Dettagli    Esporta in BibTeX    Esporta in EndNote

Leese MP, Leblond B, Smith A, Newman SP, Di Fiore A, De Simone G, Supuran CT, Purohit A, Reed MJ, Potter BVL
* 2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity (308 visite)
J Med Chem (ISSN: 0022-2623print, 0022-2623linking, 1520-4804), 2006 Dec 28; 49(26): 7683-7696.
Impact Factor: 5.115
Dettagli    Esporta in BibTeX    Esporta in EndNote

Menchise V, De Simone G, Di Fiore A, Scozzafava A, Supuran CT
* Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of 5-amino-1, 3, 4-thiadiazole-2-sulfonamide and 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)1, 3, 4-thiadiazole-2-sulfon amide to human isoform II (109 visite)
Bioorganic & Medicinal Chemistry Letters (ISSN: 0960-894x), 2006 Dec 15; 16(24): 6204-6208.
Impact Factor: 2.538
Dettagli    Esporta in BibTeX    Esporta in EndNote

Mai A, Rotili D, Tarantino D, Ornaghi P, Tosi F, Vicidomini C, Sbardella G, Nebbioso A, Miceli M, Altucci L, Filetici P
* Small-molecule inhibitors of histone acetyltransferase activity: Identification and biological properties (121 visite)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2006 Nov 16; 49(23): 6897-6907.
Impact Factor: 5.115
Dettagli    Esporta in BibTeX    Esporta in EndNote

Improta R, Barone V, Scalmani G, Frisch MJ
* A state-specific polarizable continuum model time dependent density functional theory method for excited state calculations in solution (102 visite)
J Chem Phys (ISSN: 0021-9606, 0897-690online), 2006 Sep 7; 125(5): N/D-N/D.
Impact Factor: 3.166
Dettagli    Esporta in BibTeX    Esporta in EndNote

Alterio V, Vitale RM, Monti SM, Pedone C, Scozzafava A, Cecchi A, De Simone G, Supuran CT
* Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX (120 visite)
J Am Chem Soc (ISSN: 0002-7863, 0002-2786, 1520-5126), 2006 Jun 28; 128(25): 8329-8335.
Impact Factor: 7.696
Dettagli    Esporta in BibTeX    Esporta in EndNote

De Renzo A, Perna F, Persico M, Mainolfi C, Pace L
* 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of early response in a primary hepatic lymphoma (85 visite)
Br J Haematol (ISSN: 0007-1048, 0007-1048linking, 1365-2141electronic), 2006 Jun; 133(6): 580-580.
Impact Factor: 4.498
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cappiello M, Alterio  V, Amodeo P, Del Corso A, Scaloni A, Pedone C, Moschini R, De Donatis GM, De Simone G, Mura U
* A new spot test for sulfhydryl-containing compounds (155 visite)
Anal Biochem, 2006 Mar 14; 79(1-2): 610-611.
Impact Factor: 2.305
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cappiello M, Alterio V, Amodeo P, Del Corso A, Scaloni A, Pedone C, Moschini R, De Donatis GM, De Simone G, Mura U
* Metal ion substitution in the catalytic site greatly affects the binding of sulfhydryl-containing compounds to leucyl aminopeptidase (161 visite)
Biochemistry (ISSN: 0006-2960, 1520-4995, 1520-4995electronic), 2006 Mar 14; 45(10): 3226-3234.
Impact Factor: 3.633
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cuocolo A, Acampa W, Varrone A, Salvatore M
* Highlights of the Annual Congress of the European Association of Nuclear Medicine, Istanbul, 2005: The incremental value of nuclear medicine for patient management and care (216 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Mar; 33(3): 360-381.
Impact Factor: 4.041
Dettagli    Esporta in BibTeX    Esporta in EndNote

Palumbo R, Capasso D, Brescia F, Mita P, Sarti M, Bersani F, Scarfi MR
* Effects on apoptosis and reactive oxygen species formation by Jurkat cells exposed to 50 Hz electromagnetic fields (82 visite)
Bioelectromagnetics (ISSN: 0197-8462), 2006 Feb; 27(2): 159-162.
Impact Factor: 1.514
Dettagli    Esporta in BibTeX    Esporta in EndNote

D'Andrea LD, Del Gatto A, Pedone C, Benedetti E
* Peptide-based molecules in angiogenesis (154 visite)
Chem Biol Drug Des Chemical Biology And Drug Design (ISSN: 1747-0277, 1747-0285), 2006 Feb; 67(2): 115-126.
Impact Factor: 2.507
Dettagli    Esporta in BibTeX    Esporta in EndNote

Arena G, Casnati A, Contino A, Magrì A, Sansone F, Sciotto D, Ungaro R
* Inclusion of naturally occurring amino acids in water soluble calix[4]arenes: A microcalorimetric and 1H NMR investigation supported by molecular modeling (122 visite)
Org Biomol Chem (ISSN: 1477-0520, 1477-0539, 1477-0539electronic), 2006 Jan 21; 4(2): 243-249.
Impact Factor: 2.874
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Zannetti A, Salvatore B, Paone G, Fonti R, Salvatore M
* Functional imaging of multidrug resistance in breast cancer (105 visite)
Phys Med (ISSN: 1120-1797, 1120-1797linking), 2006; 21(SUPPL.1): 24-27.
Impact Factor: 0.313
Dettagli    Esporta in BibTeX    Esporta in EndNote

Grasso G, D'Agata R, Rizzarelli E, Spoto G, D'Andrea LD, Pedone C, Picardi A, Romanelli A, Fragai M, Yeo KJ
* Activity of anchored human matrix metalloproteinase-1 catalytic domain on Au(111) surfaces monitored by ESI-MS (107 visite)
J Mass Spectrom Journal Of Mass Spectrometry (ISSN: 1076-5174, 1096-9888), 2005 Dec; 40(12): 1565-1571.
Impact Factor: 3.574
Dettagli    Esporta in BibTeX    Esporta in EndNote

Menchise V, De Simone G, Alterio V, Di Fiore A, Pedone C, Scozzafava A, Supuran CT
* Carbonic anhydrase inhibitors: Stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II (141 visite)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2005 Sep 8; 48(18): 5721-5727.
Impact Factor: 4.926
Dettagli    Esporta in BibTeX    Esporta in EndNote

Marrazzo A, Caraci F, Salinaro ET, Su TP, Copani A, Ronsisvalle G
* Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity (107 visite)
Neuroreport (ISSN: 0959-4965), 2005 Sep 1; 16(11): 1223-1226.
Impact Factor: 1.995
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pace L, Catalano L, Del Vecchio S, De Renzo A, Fonti R, Salvatore B, Andretta C, Di Nuzzo C, Rotoli B, Salvatore M
* Washout of [99mTc] sestamibi in predicting response to chemotherapy in patients with multiple myeloma (137 visite)
Q J Nucl Med Mol Imaging (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2005 Sep; 49(3): 281-285.
Impact Factor: 1.724
Dettagli    Esporta in BibTeX    Esporta in EndNote

Verdoliva A, Marasco D, De Capua A, Saporito A, Bellofiore P, Manfredi V, Fattorusso R, Pedone C, Ruvo M
* A new ligand for immunoglobulin G subdomains by screening of a synthetic peptide library (126 visite)
Chembiochem (ISSN: 1439-4227, 1439-7633, 1439-7633electronic), 2005 Jul; 6(7): 1242-1253.
Impact Factor: 3.94
Dettagli    Esporta in BibTeX    Esporta in EndNote

Naddeo M, Vitagliano L, Russo A, Gotte G, D'Alessio G, Sorrentino S
* Interactions of the cytotoxic RNase A dimers with the cytosolic ribonuclease inhibitor (87 visite)
Febs Lett (ISSN: 0014-5793, 0014-5793print, 1873-3468electronic), 2005 May 9; 579(12): 2663-2668.
Impact Factor: 3.415
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cozzolino R, Palladino P, Rossi F, Cali G, Benedetti E, Laccetti P
* Antineoplastic cyclic astin analogues kill tumour cells via caspase-mediated induction of apoptosis (165 visite)
Carcinogenesis (ISSN: 0143-3334), 2005 Apr; 26(4): 733-739.
Impact Factor: 5.108
Dettagli    Esporta in BibTeX    Esporta in EndNote

Tauchmanovà L, Pensabene M, Capuano I, Spagnoletti I, Zeppa P, Del Vecchio S, Mainenti PP, De Rosa G, Colao A, Contegiacomo A
* Poorly differentiated small cell neuroendocrine carcinoma localized in three different endocrine glands: Response to chemotherapy and octreotide LAR (110 visite)
J Endocrinol Invest (ISSN: 0391-4097, 1720-8386electronic), 2005 Apr; 28(4): 371-378.
Impact Factor: 1.496
Dettagli    Esporta in BibTeX    Esporta in EndNote

La Rosa C, Milardi D, Amato E, Pappalardo M, Grasso D
* Molecular mechanism of the inhibition of cytochrome c aggregation by Phe-Gly (157 visite)
Arch Biochem Biophys (ISSN: 0003-9861), 2005 Mar 1; 435(1): 182-189.
Impact Factor: 3.152
Dettagli    Esporta in BibTeX    Esporta in EndNote

Paesano N, Marzocco S, Vicidomini C, Saturnino C, Autore G, De Martino G, Sbardella G
* Synthesis and biological evaluation of 3-benzyl-1-methyl- and 1-methyl-3-phenyl-isothioureas as potential inhibitors of iNOS (120 visite)
Bioorganic & Medicinal Chemistry Letters (ISSN: 0960-894x), 2005 Feb 1; 15(3): 539-543.
Impact Factor: 2.478
Dettagli    Esporta in BibTeX    Esporta in EndNote

Russo M, Tedesco I, Iacomino G, Palumbo R, Galano G, Russo GL
* Dietary phytochemicals in chemoprevention of cancer (107 visite)
Curr Med Chem (ISSN: 1568-0134), 2005; 5(1): 61-72.
Impact Factor: 3.715
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Salvatore M
* Tc-99m-MIBI in the evaluation of breast cancer biology (215 visite) (PDF 68 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2004 Jun; 31(SUPPL.1): S88-S88.
Impact Factor: 3.935
Dettagli    Esporta in BibTeX    Esporta in EndNote

Musumeci D, Roviello  GN, Sica D
* The oxidation of Δ2, Δ2, 4 and Δ4, 6 steroids with RuO4 (124 visite)
Steroids (ISSN: 0039-128x), 2004 Mar; 69(3): 173-179.
Impact Factor: 2.337
Dettagli    Esporta in BibTeX    Esporta in EndNote

Rossi F, Zanotti G, Saviano M, Iacovino R, Palladino P, Saviano G, Amodeo P, Tancredi T, Laccetti P, Corbier C, Benedetti E
* New antitumour cyclic astin analogues: Synthesis, conformation and bioactivity (103 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2004 Feb; 10(2): 92-102.
Impact Factor: 1.652
Dettagli    Esporta in BibTeX    Esporta in EndNote

Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Catalano L, Pace L, Rotoli B, Salvatore M
* Functional Imaging Of Multidrug Resistant Phenotype By 99mtc-Mibi Scan In Patients With Multiple Myeloma (111 visite)
Cancer Biotherapy And Radiopharmaceuticals (ISSN: 1084-9785, 1084-4978), 2004; 19(2): 165-170.
Impact Factor: 1.091
Dettagli    Esporta in BibTeX    Esporta in EndNote

D'Auria G, Flores G, Falcigno L, Oliva R, Vacatello M, Corsaro MM, Parrilli M, Paolillo L
* Hyaluronate tetrasaccharide-Cu(II) interaction: A NMR study (116 visite)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2003 Oct; 70(2): 260-269.
Impact Factor: 2.733
Dettagli    Esporta in BibTeX    Esporta in EndNote

Andretta C, Catalano L, Pace L, Fonti R, Annunziata G, Rotoli B
* 99mTc-sestaMIBI scintigraphy in thalidomide-treated refractory or relapsed multiple myeloma patients [2] (99 visite)
Leuk Lymphoma (ISSN: 1042-8194, 1026-8022linking), 2003 Jun; 44(6): 1081-1082.
Impact Factor: 1.163
Dettagli    Esporta in BibTeX    Esporta in EndNote

Spalletti-cernia D, Sorrentino R, Di Gaetano S, Arciello A, Garbi C, Piccoli R, D'Alessio G, Vecchio G, Laccetti P, Santoro M
* Antineoplastic ribonucleases selectively kill thyroid carcinoma cells via caspase-mediated induction of apoptosis (118 visite)
Journal Of Clinical Endocrinology & Metabolism (ISSN: 0021-972x), 2003 Jun; 88(6): 2900-2907.
Impact Factor: 5.873
Dettagli    Esporta in BibTeX    Esporta in EndNote

De Luca S, Ulhaq S, Dixon M J, EssexJ, Bradley M
* Solid-phase synthesis of a focused library of trypanothione reductase inhibitors (112 visite)
Tetrahedron Lett (ISSN: 0040-4039), 2003 Apr 7; 44(15): 3195-3197.
Impact Factor: 2.326
Dettagli    Esporta in BibTeX    Esporta in EndNote

Kim KM, Varrone A, Watabe H, Shidahara M, Fujita M, Innis RB, Iida H
* Contribution of scatter and attenuation compensation to SPECT images of nonuniformly distributed brain activities (129 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2003 Apr; 44(4): 512-519.
Impact Factor: 4.899
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Zannetti A, Aloj L, Salvatore M
* MIBI as prognostic factor in breast cancer (96 visite)
Q J Nucl Med (ISSN: 1124-3937, 1125-0135), 2003 Mar; 47(1): 46-50.
Impact Factor: 2.222
Dettagli    Esporta in BibTeX    Esporta in EndNote

Colao A, Marzullo P, Cuocolo A, Spinelli L, Pivonello R, Bonaduce D, Salvatore M, Lombardi G
* Reversal of acromegalic cardiomyopathy in young but not in middle-aged patients after 12 months of treatment with the depot long-acting somatostatin analogue octreotide (124 visite)
Clin Endocrinol (ISSN: 0300-0664, 1365-2265, 1365-2265electronic), 2003 Feb; 58(2): 169-176.
Impact Factor: 2.767
Dettagli    Esporta in BibTeX    Esporta in EndNote

Saracino GA, Improta R, Scalmani G, Barone V
* Absolute pKa determination for carboxylic acids using density functional theory and the polarizable continuum model (124 visite)
Chemical Physics Letters (ISSN: 0009-2614), 2003; 373(3-4): 411-415.
Impact Factor: 2.438
Dettagli    Esporta in BibTeX    Esporta in EndNote

Leosco D, Iaccarino G, Cipolletta E, De Santis D, Pisani E, Trimarco V, Ferrara N, Abete P, Sorriento D, Rengo F, Trimarco B
* Exercise restores β-adrenergic vasorelaxation in aged rat carotid arteries (105 visite)
Am J Physiol Heart Circ Physiol American Journal Of Physiology Heart And Circulatory Physiology (ISSN: 0363-6135), 2003; 285(154-1): H369-H369.
Impact Factor: 3.658
Dettagli    Esporta in BibTeX    Esporta in EndNote

Russo M, Palumbo R, Mupo A, Tosto M, Iacomino G, Scognamiglio A, Tedesco I, Galano G, Russo GL
* Flavonoid quercetin sensitizes a CD95-resistant cell line to apoptosis by activating protein kinase Cα (141 visite)
Oncogene (ISSN: 0950-9232, 1476-5594), 2003; 22(21): 3330-3342.
Impact Factor: 6.495
Dettagli    Esporta in BibTeX    Esporta in EndNote

Camera L, Del Vecchio S, Quarantelli M, Ibello F, Pellegrino T, Salvatore M
* Radiolabeled somatostatin analogs in the diagnosis and staging of neuroendocrine tumors (103 visite)
J Endocrinol Invest (ISSN: 0391-4097, 1720-8386electronic), 2003; 26(8Suppl): 60-62.
Impact Factor: 1.621
Dettagli    Esporta in BibTeX    Esporta in EndNote

Tabbì G, Cassino C, Cavigiolio G, Colangelo D, Ghiglia A, Viano I, Osella D
* Water stability and cytotoxic activity relationship of a series of ferrocenium derivatives. ESR insights on the radical production during the degradation process (131 visite)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2002 Dec 19; 45(26): 5786-5796.
Impact Factor: 4.566
Dettagli    Esporta in BibTeX    Esporta in EndNote

Romano M, Giojelli A, Mainenti PP, Tamburrini O, Salvatore M
* Upper thoracic sympathetic chain neurolysis under CT guidance. A two year follow-up in patients with palmar and axillary hyperhidrosis (98 visite)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic), 2002 Nov; 104(5-6): 421-425.
Impact Factor: 1.368
Dettagli    Esporta in BibTeX    Esporta in EndNote

Morelli G, De Luca S, Tesauro D, Saviano M, Pedone C, Dolmella A, Visentin R, Mazzi U
* CCK8 peptide derivatized with diphenylphosphine for rhenium labelling: Synthesis and molecular mechanics calculations (100 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2002 Jul; 8(7): 373-381.
Impact Factor: 1.691
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Zannetti A, Ciarmiello A, Aloj L, Caracò C, Fonti R, Botti G, D'Aiuto G, Salvatore M
* Dynamic coupling of Tc-99m-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients (128 visite)
Eur J Nucl Med (ISSN: 1619-7070, 0340-6997, 1619-7089), 2002 Jun; 29(6): 809-814.
Impact Factor: 3.568
Dettagli    Esporta in BibTeX    Esporta in EndNote

Marino M, Rossi M, Ruvo M, Fassina G
* Novel molecular targets for systemic lupus erythematosus (105 visite)
Curr Drug Targets (ISSN: 1389-4501), 2002 Jun; 3(3): 223-228.
Impact Factor: 3.597
Dettagli    Esporta in BibTeX    Esporta in EndNote

Formaggio F, Bonchio M, Crisma M, Peggion C, Mezzato S, Polese A, Barazza A, Antonello S, Maran F, Broxterman QB, Kaptein B, Kamphuis J, Vitale RM, Saviano M, Benedetti E, Toniolo C
* Nitroxyl peptides as catalysts of enantioselective oxidations (143 visite)
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2002; 8(1): [d]84-93.
Impact Factor: 4.238
Dettagli    Esporta in BibTeX    Esporta in EndNote

Danforth Dn JR, Aloj L, Carrasquillo JA, Bacharach SL, Chow C, Zujewski J, Whatley M, Galen B, Merino M, Neumann RD
* The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancer (93 visite)
Breast Cancer Res Tr Kluwer Academic Publishers (ISSN: 0167-6806), 2002; 75(2): 135-146.
Impact Factor: 3.132
Dettagli    Esporta in BibTeX    Esporta in EndNote

Fassina G, Ruvo M, Palombo G, Verdoliva A, Marino M
* Novel ligands for the affinity-chromatographic purification of antibodies (159 visite)
J Biochem Biophys Methods (ISSN: 0165-022x, 0165-022xlinking), 2001 Oct 30; 49(1-3): 481-490.
Impact Factor: 1.218
Dettagli    Esporta in BibTeX    Esporta in EndNote

Monti SM, Ritieni A, Sacchi R, Skog K, Borgen E, Fogliano V
* Characterization of phenolic compounds in virgin olive oil and their effect on the formation of carcinogenic/mutagenic heterocyclic amines in a model system (132 visite)
J Agric Food Chem (ISSN: 0021-8561), 2001 Sep; 49(8): 3969-3975.
Impact Factor: 1.576
Dettagli    Esporta in BibTeX    Esporta in EndNote

Garzillo AM, Colao MC, Buonocore V, Oliva R, Falcigno L, Saviano M, Santoro AM, Zappala R, Bonomo RP, Bianco C, Giardina P, Palmieri G, Sannia G
* Structural and kinetic characterization of native laccases from Pleurotas ostreatus, Rigidoporus lignosus, and Trametes trogii (111 visite)
Journal Of Protein Chemistry (ISSN: 0277-8033), 2001 Apr; 20(3): 191-201.
Impact Factor: 1.021
Dettagli    Esporta in BibTeX    Esporta in EndNote

Romanelli A, Garella I, Menchise V, Iacovino R, Saviano M, Montesarchio D, Didierjean C, Lello PD, Rossi F, Benedetti E
* Crystal-state conformation of Cα, α-dialkylated peptides containing chiral β-homo-residues (128 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2001; 7(1): 15-26.
Impact Factor: 1.451
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Ciarmiello A, Salvatore M
Scintigraphic detection of multidrug resistance in cancer (97 visite)
Cancer Biotherapy And Radiopharmaceuticals (ISSN: 1084-9785, 1084-4978), 2000 Sep; 15(4): 327-337.
Impact Factor: 0.989
Dettagli    Esporta in BibTeX    Esporta in EndNote

Colasanti A, Kisslinger A, Liuzzi R, Quarto M, Riccio P, Roberti G, Tramontano D, Villani F
Hypericin photosensitization of tumor and metastatic cell lines of human prostate (64 visite)
J Photochem Photobiol B (ISSN: 1011-1344print, 1011-1344linking), 2000 Feb; 54(2-3): 103-107.
Impact Factor: 1.529
Dettagli    Esporta in BibTeX    Esporta in EndNote

Russo M, Palumbo R, Tedesco I, Mazzarella G, Russo P, Iacomino G, Russo GL
Quercetin and anti-CD95(Fas/Apo1) enhance apoptosis in HPB-ALL cell line (96 visite)
Febs Lett (ISSN: 0014-5793, 0014-5793print, 1873-3468electronic), 1999 Dec 3; 462(3): 322-328.
Impact Factor: 3.72
Dettagli    Esporta in BibTeX    Esporta in EndNote

Caliendo G, Fiorino F, Grieco P, Perissutti E, De Luca S, Giuliano A, Santelli G, Califano D, Severino B, Santagada V
Synthesis and biological activity of pseudopeptides inhibitors of Ras farnesyl transferase containing unconventional amino acids (128 visite)
Farmaco (ISSN: 0014-827x), 1999 Nov; 54(11-12): 785-790.
Impact Factor: 0.406
Dettagli    Esporta in BibTeX    Esporta in EndNote

Fogliano V, Ritieni A, Monti SM, Gallo M, Della Medaglia D, Ambrosino ML, Sacchi R
Antioxidant activity of virgin olive oil phenolic compounds in a micellar system (97 visite)
Journal Of The Science Of Food And Agriculture (ISSN: 0022-5142), 1999 Oct; 79(13): 1803-1808.
Impact Factor: 1.097
Dettagli    Esporta in BibTeX    Esporta in EndNote

Herscher LL, Cook JA, Pacelli R, Pass HI, Russo A, Mitchell JB
Principles of chemoradiation: Theoretical and practical considerations (104 visite)
Oncology (ISSN: 0890-9091), 1999 Oct; 13(10SUPPL.5): 11-22.
Impact Factor: 0.933
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Ciarmiello A, Salvatore M
Clinical imaging of multidrug resistance in cancer (116 visite)
Q J Nucl Med (ISSN: 1124-3937, 1125-0135), 1999 Jun; 43(2): 125-131.
Impact Factor: 2.125
Dettagli    Esporta in BibTeX    Esporta in EndNote

Fonti R, Levchenko A, Mehta BM, Zhang J, Tsuruo T, Larson SM
Measurement of P-glycoprotein expression in human neuroblastoma xenografts using in vitro quantitative autoradiography (86 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1999 Jan; 26(1): 35-41.
Impact Factor: 1.623
Dettagli    Esporta in BibTeX    Esporta in EndNote

Monti SM, Fogliano V, Randazzo G, Peluso G, Logrieco A, Ritieni A
Polyclonal antibodies against fusaproliferin (78 visite)
Can J Microbiol (ISSN: 0008-4166), 1999 Jan; 45(1): 45-50.
Impact Factor: 1.072
Dettagli    Esporta in BibTeX    Esporta in EndNote

Fonti R, Cheung N-KV, Bridger GJ, Guo H-F, Abrams MJ, Larson SM
99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors (101 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1999; 26(6): 681-686.
Impact Factor: 1.623
Dettagli    Esporta in BibTeX    Esporta in EndNote

Fonti R, Cheung NKV, Bridger GJ, Shen SQ, Finn RD, Abrams RJ, Larson SM
Technetium-99m-Monoclonal Antibody Radio-Labeled Via Hydrazino Nicotinamide Derivative For Imaging Ganglioside Gd2-Positive Tumors (85 visite)
Nucl Med Biol, 1999; 26: 681-686.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Renda A, Iovino F, Capasso L, Ricciardelli L, Tammaro V, Acampa W
Radioimmunoguided surgery in colorectal cancer: A 6-year experience with four different technical solutions (95 visite)
Semin Surg Oncol Wiley Liss Inc (ISSN: 8756-0437), 1998 Dec; 15(4): 226-230.
Impact Factor: 1.045
Dettagli    Esporta in BibTeX    Esporta in EndNote

Imbriaco M, De Iuri A, Camera L
Isolated uterine relapse in a child with acute lymphoblastic leukemia (75 visite)
Ajr Am J Roentgenol (ISSN: 0361-803x), 1998 Oct; 171(4): 1166-1167.
Impact Factor: 2.179
Dettagli    Esporta in BibTeX    Esporta in EndNote

Pace L, Catalano L, Pinto A, De Renzo A, Di Gennaro F, Califano C, Del Vecchio S, Rotoli B, Salvatore M
Different patterns of technetium-99m sestamibi uptake in multiple myeloma (119 visite)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1998 Jul; 25(7): 714-720.
Impact Factor: 2.564
Dettagli    Esporta in BibTeX    Esporta in EndNote

Salvatore M, Del Vecchio S
Dynamic imaging: Scintimammography (139 visite)
Eur J Radiol Elsevier Sci Ireland Ltd (ISSN: 0720-048x), 1998 May; 27(SUPPL.2): S259-S259.
Impact Factor: 0.537
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ciarmiello A, Del Vecchio S, Silvestro P, Potena MI, Carriero MV, Thomas R, Botti G, D'Aiuto G, Salvatore M
Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer (139 visite)
Journal Of Clinical Oncology (ISSN: 0732-183x), 1998 May; 16(5): 1677-1683.
Impact Factor: 8.228
Dettagli    Esporta in BibTeX    Esporta in EndNote

Klain M, Cuocolo A, Salvatore M, Maurea S
Tetrofosmin thyroid scintigraphy [1] (84 visite)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1998; 25(7): 816-816.
Impact Factor: 2.564
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gatos M, Formaggio F, Crisma M, Valle G, Toniolo C, Bonora GM, Saviano M, Iacovino R, Menchise V, Galdiero S, Pedone C, Benedetti E
Conformational Characterization Of Peptides Rich In The Cycloaliphatic C Alpha, Alpha-Disubstituted Glycine 1-Aminocyclononane-1-Carboxylic Acid (135 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 1997 Sep; 3(5): 367-382.
Impact Factor: 1.311
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Ciarmiello A, Pace L, Potena MI, Carriero MV, Mainolfi C, Thomas R, D'Aiuto G, Tsuruo T, Salvatore M
Fractional retention of technetium-99m-sestamibi as an index of P- glycoprotein expression in untreated breast cancer patients (89 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1997 Sep; 38(9): 1348-1351.
Impact Factor: 3.491
Dettagli    Esporta in BibTeX    Esporta in EndNote

Wink DA, Cook JA, Christodoulou D, Krishna MC, Pacelli R, Kim S, DeGraff W, Gamson J, Vodovotz Y, Russo A, Mitchell JB
Nitric oxide and some nitric oxide donor compounds enhance the cytotoxicity of cisplatin (92 visite)
Nitric Oxide Biology And Chemistry (ISSN: 1089-8603), 1997 Feb; 1(1): 88-94.
Impact Factor: 2.151
Dettagli    Esporta in BibTeX    Esporta in EndNote

Crisma M, Formaggio F, Valle G, Toniolo C, Saviano M, Iacovino R, Zaccaro L, Benedetti E
Experimental evidence at atomic resolution for intramolecular N- H···π (phenyl) interactions in a family of amino acid derivatives (122 visite)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 1997; 42(1): 1-6.
Impact Factor: 2.425
Dettagli    Esporta in BibTeX    Esporta in EndNote

Iaffaioli RV, Facchini G, Tortoriello A, Scala S, Pacelli R, La Mura G, Pagliarulo C, Palmieri G, Caponigro F
Modulation of chemosensitivity by alpha interferon in multiple myeloma and non-Hodgkin's lymphoma (108 visite)
J Exp Ther Oncol (ISSN: 1359-4117), 1996 Jul; 1(4): 226-230.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Levchenko A, Mehta B, Spengler BA, Narkar A, Fonti R, Biedler JL, Tsuruo T, Larson SM
Measurement of P-glycoprotein expression in multidrug-resistant human neuroblastoma cell lines using self-competitive binding assay (104 visite)
Anal Biochem (ISSN: 0003-2697, 1096-0309electronic), 1996 May 1; 236(2): 338-343.
Impact Factor: 2.017
Dettagli    Esporta in BibTeX    Esporta in EndNote

Li PY, Del Vecchio S, Fonti R, Carriero MV, Potena MI, Botti G, Miotti S, Lastoria S, Menard S, Colnaghi MI, Salvatore M
Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography (158 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1996 Apr; 37(4-6): 665-672.
Impact Factor: 3.491
Dettagli    Esporta in BibTeX    Esporta in EndNote

Morisco C, Cuocolo A,  Romano M, Nappi A, Iaccarino G, Volpe M, Salvatore M, Trimarco B
Influence of digitalis on left ventricular functional response to exercise in congestive heart failure (96 visite)
Am J Cardiol (ISSN: 0002-9149), 1996 Mar 1; 77(7): 480-485.
Impact Factor: 2.402
Dettagli    Esporta in BibTeX    Esporta in EndNote

Latella G, Fonti R, Caprilli R, Marcheggiano A, Magliocca F, Das KM, Gambús G, Sambuy Y
Characterization of the mucins produced by normal human colonocytes in primary culture (93 visite)
International Journal Of Colorectal Disease (ISSN: 0179-1958, 0179-1958linking), 1996; 11(2): 76-83.
Impact Factor: 0.732
Dettagli    Esporta in BibTeX    Esporta in EndNote

Wink DA, Hanbauer I, Grisham MB, Laval F, Nims RW, Laval J, Cook J, Pacelli R, Liebmann J, Krishna M, Ford PC, Mitchell JB
Chemical biology of nitric oxide: Regulation and protective and toxic mechanisms (80 visite)
Current Topics In Cellular Regulation (ISSN: 0070-2137), 1996; 34: 159-187.
Impact Factor: 4.375
Dettagli    Esporta in BibTeX    Esporta in EndNote

CAPASSO S, SICA F, MAZZARELLA L, BALBONI G, GUERRINI R, SALVADORI S
ACID CATALYSIS IN THE FORMATION OF DIOXOPIPERAZINES FROM PEPTIDES CONTAINING TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACID AT POSITION-2 (113 visite)
Int J Pept Protein Res (ISSN: 0367-8377, 0367-8377print), 1995 Jun; 45(6): 567-573.
Impact Factor: 1.255
Dettagli    Esporta in BibTeX    Esporta in EndNote

Carriero MV, Franco P, Del Vecchio S, Massa O, Botti G, D'Aiuto G, Stoppelli MP, Salvatore M
Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies (107 visite)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1994 Oct 15; 54(20): 5445-5454.
Impact Factor: 8.426
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cucinotta V, Mangano A, Nobile G, Santoro AM, Vecchio G
New platinum(II) complexes of β-cyclodextrin diamine derivatives and their antitumor activity (100 visite)
J Chem Res (ISSN: 0162-0134, 1873-3344, 0162-0134print), 1993 Nov 15; 52(3): 183-190.
Impact Factor: 1.342
Dettagli    Esporta in BibTeX    Esporta in EndNote

Morisco C, Argenziano L, Sarno D, Cuocolo A,  Romano M, Trimarco B
The practical aspects of treatment in heart failure (65 visite)
Ann Ital Med Int (ISSN: 0393-9340), 1993 Oct; 8Suppl: 14S-19S.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Caraglia M, Tagliaferri P, Correale P, Genua G, Pinto A, Del Vecchio S, Esposito G, Bianco AR
CYTOSINE-ARABINOSIDE INCREASES THE BINDING OF I-125 LABELED EPIDERMAL GROWTH-FACTOR AND I-125 TRANSFERRIN AND ENHANCES THE IN-VITRO TARGETING OF HUMAN TUMOR-CELLS WITH ANTI-(GROWTH FACTOR-RECEPTOR) MAB (118 visite)
Cancer Immunol Immunother (ISSN: 0340-7004, 0340-7004linking), 1993 Sep; 37(3): 150-156.
Impact Factor: 1.269
Dettagli    Esporta in BibTeX    Esporta in EndNote

Caraglia M, Tagliaferri P, Correale P, Genua G, Pinto A, Del Vecchio S, Esposito G, Bianco AR
Cytosine arabinoside increases the binding of 125I-labelled epidermal growth factor and 125I-transferrin and enhances the in vitro targeting of human tumour cells with anti-(growth factor receptor) mAb (3 visite)
Cancer Immunol Immunother (ISSN: 0340-7004linking), 1993 Aug; 37 (3 ): 150-156.
Impact Factor: 4.293
Dettagli    Esporta in BibTeX    Esporta in EndNote

Arena G, Bindoni M, Cardile V, Maccarrone G, Riello MC, Rizzarelli E, Sciuto S
Cytotoxic and cytostatic activity of copper(II) complexes. Importance of the speciation for the correct interpretation of the in vitro biological results (137 visite)
J Chem Res (ISSN: 0162-0134, 1873-3344, 0162-0134print), 1993 Apr 1; 50(1): 31-45.
Impact Factor: 1.342
Dettagli    Esporta in BibTeX    Esporta in EndNote

Sofia M, Del Vecchio S, Petrillo A, Mormile M, Salvatore M, Carratù L
Endobronchial deposition of radioactive monoclonal antibody in patients with inoperable non-small-cell carcinoma of the lung [4] (88 visite)
Chest (ISSN: 0012-3692), 1992 Nov; 102(5): 1632-1634.
Impact Factor: 2.341
Dettagli    Esporta in BibTeX    Esporta in EndNote

D'Aiuto G, Del Vecchio S, Mansi L, D'Aprile M, Botti G, Salvatore M
Malignant melanoma of the nipple: A case studied with radiolabeled monoclonal antibody (105 visite)
Tumori (ISSN: 0300-8916, 0300-8916print), 1991 Oct 31; 77(5): 449-451.
Impact Factor: 0.408
Dettagli    Esporta in BibTeX    Esporta in EndNote

Manna R, Salvatore M, Di Leo MA, Scuderi F, Greco AV, Ghirlanda G, Gambassi G
Relationship between urinary neopterin excretion and islet cell antibodies in type 1 (insulin-dependent) diabetes (93 visite)
Diabetes Res (ISSN: 0265-5985), 1991 May; 17(1): 33-36.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

Camera L, Del Vecchio S, Petrillo A, Esposito G, Frasci G, Iaffaioli RV, Bianco AR, Salvatore M
Evaluation of therapeutic response using iodine-131-B72. 3 monoclonal antibody in patients with ovarian carcinoma (118 visite)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1991 Apr; 18(4): 269-273.
Impact Factor: 2.692
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Camera L, Petrillo A, Esposito G, Frasci G, Iaffaioli RV, Bianco AR, Salvatore M
Clinical studies with B72. 3 in ovarian cancer and probe-guided tumor localization (113 visite)
Nucl Med Biol (ISSN: 0883-2897, 0969-8051), 1991; 18(1): 85-87.
Impact Factor: 1.042
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Mansi L, Petrillo A, Camera L, Sofia M, Marra A, Carratú L, Salvatore M
Endobronchial administration of iodine-131 B72. 3 monoclonal antibody in patients with lung cancer (107 visite)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1991; 18(2): 129-132.
Impact Factor: 2.692
Dettagli    Esporta in BibTeX    Esporta in EndNote

Papa V, Reese CC, Brunetti A, Vigneri R, Siiteri PK, Goldfine ID
Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinoma cells (82 visite)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1990 Dec 15; 50(24): 7858-7862.
Impact Factor: 8.426
Dettagli    Esporta in BibTeX    Esporta in EndNote

Valenza V, Maussier ML, D'Errico G, Lemmo GF, Frontera D, Ferrante A, Saletnich I, Valli A, Quarantelli M
Cancer of the pancreas and the periampullary region: The usefulness of tumor marker products with the monoclonal antibody technique (76 visite)
J Nucl Med Allied Sci (ISSN: 0392-0208), 1990 Oct; 34(4SUPPL.): 131-134.
Impact Factor: 1.91
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Reynolds JC
NONUNIFORM DISTRIBUTION OF RADIOLABELED MONOCLONAL-ANTIBODY IN TUMOR (92 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1990 Jul; 31(7): 1252-1252.
Impact Factor: 3.491
Dettagli    Esporta in BibTeX    Esporta in EndNote

Steis RG, Carrasquillo JA, Mccabe R, Bookman MA, Reynolds JC, Larson SM, Smith JW, Clark JW, Dailey V, Del Vecchio S
Toxicity, immunogenicity, and tumor radioimmunodetecting ability of two human monoclonal antibodies in patients with metastatic colorectal carcinoma (93 visite)
J Clin Oncol (ISSN: 0732-183x, 0732-183xlinking), 1990 Mar; 8(3): 476-490.
Impact Factor: 7.878
Dettagli    Esporta in BibTeX    Esporta in EndNote

Trischitta V, Wong KY,  Brunetti A, Scalisi R, Vigneri R, Goldfine ID
Endocytosis, recycling, and degradation of the insulin receptor. Studies with monoclonal antireceptor antibodies that do not activate receptor kinase (88 visite)
J Biol Chem Journal Of Biological Chemistry (ISSN: 0021-9258, 1083-351x), 1989 Mar 25; 264(9): 5041-5046.
Impact Factor: 6.963
Dettagli    Esporta in BibTeX    Esporta in EndNote

d'Onofrio G, Menichella G, Zini G, Rumi C, Pierelli L, Quarantelli M, Puggioni PL, Mango G
Lymphocyte subset counting by immunoperoxidase using an automated routine hematologic analyzer (90 visite)
Haematologica (ISSN: 0390-6078, 0006-4971, 0006-6497), 1989 Mar; 74(2): 137-142.
Impact Factor: 2.56
Dettagli    Esporta in BibTeX    Esporta in EndNote

Reynolds JC, Del Vecchio S, Sakahara H, Lora ME, Carrasquillo JA, Neumann RD, Larson SM
ANTI-MURINE ANTIBODY RESPONSE TO MOUSE MONOCLONAL ANTIBODIES CLINICAL FINDINGS AND IMPLICATIONS (90 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1989; 16(2): 121-125.
Impact Factor: 1.042
Dettagli    Esporta in BibTeX    Esporta in EndNote

Salvatore M, Lastoria S, Del Vecchio S, Mansi L
Detection of colon cancer with radiolabelled monoclonal antibodies (107 visite)
Nucl Med Biol (ISSN: 0883-2897, 0969-8051), 1989; 16(2): 103-104.
Impact Factor: 1.042
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Reynolds JC
DETERMINATION OF ANTIGEN CONCENTRATION AND DISTRIBUTION IN HUMAN TUMORS THE QUANTITATIVE AUTORADIOGRAPHIC APPROACH (91 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1989; 16(2): 143-145.
Impact Factor: 1.042
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Reynolds JC, Carrasquillo JA, Blasberg RG, Neumann RD, Lotze MT, Bryant GJ, Farkas RJ, Larson SM
Local distribution and concentration of intravenously injected 131I-9. 2. 27 monoclonal antibody in human malignant melanoma (97 visite)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1989; 49(10): 2783-2789.
Impact Factor: 8.426
Dettagli    Esporta in BibTeX    Esporta in EndNote

Manna R, Salvatore M, Scuderi F, Papa G, Marietti G, Greco AV, Ghirlanda G, Gambassi G
Negative correlation between ICA persistence and beta cell restoration after IDDM diagnosis (79 visite)
Diabetes Res (ISSN: 0265-5985), 1988 Nov; 9(3): 101-103.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

DEL VECCHIO S, MANSI L, GAGLIARDI N, PETRILLO A, SOFIA M, CARRATU L, SALVATORE M
INTRABRONCHIAL ADMINISTRATION OF IODINE-131 B72. 3 MONOCLONAL ANTIBODY IN PATIENTS WITH LUNG CANCER (83 visite)
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1988; 14(5-6): N/D-N/D.
Impact Factor: 2.692
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Vecchio S, Reynolds JC, Blasberg RG, Neumann RD, Carrasquillo JA, Hellström I, Larson SM
Measurement of local Mr 97, 000 and 250, 000 protein antigen concentration in sections of human melanoma tumor using in vitro quantitative autoradiography (102 visite)
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1988; 48(19): 5475-5481.
Impact Factor: 8.426
Dettagli    Esporta in BibTeX    Esporta in EndNote

Alfano B, Coucourde F, Malgieri F, Ragozzino A
PET/CT and radiotherapy (138 visite)
Q J Nucl Med Mol Imaging, 1980 Oct; 50(1): 4-14.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote



268 Records (250 escludendo Abstract e Conferenze).
Impact factor totale: 956.724 (894.733 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 1023.244 (952.145 escludendo Abstract e Conferenze).







    Esporta in BibTeX    Esporta in EndNote

Ultima modifica di Gennaro Angrisano in data Monday 08 October 2018, 12:40:37
45 visite. Ultima visita in data Wednesday 20 February 2019, 11:05:21

Webmaster and developer: Marco Comerci
Per problemi e suggerimenti: adminibb.cnr.it
Ultimo aggiornamento: Wednesday 20 February 2019, 11:48:26